CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: succimer
Accession: CHEBI:63623
browse the term
Definition: A sulfur-containing carboxylic acid that is succinic acid bearing two mercapto substituents at positions 2 and 3. A lead chelator used as an antedote to lead poisoning.
Synonyms: exact_synonym: (2R,3S)-2,3-disulfanylsuccinic acid
related_synonym: (R*,S*)-2,3-Dimercaptobutanedioic acid; DMSA; Dimercaptosuccinic acid; Formula=C4H6O4S2; InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+; InChIKey=ACTRVOBWPAIOHC-XIXRPRMCSA-N; SMILES=OC(=O)[C@@H](S)[C@@H](S)C(O)=O; meso-2,3-Dimercaptobernsteinsaeure; meso-2,3-Dimercaptosuccinic acid; meso-Dimercaptosuccinic acid; succimero; succimerum
alt_id: CHEBI:9303
xref: Beilstein:1725150; CAS:304-55-2; DrugBank:DB00566; Drug_Central:2486; KEGG:C07598; KEGG:D00572; LINCS:LSM-4749
xref_mesh: MESH:D004113
xref: PMID:19123743; PMID:21112928; PMID:22234625; Reaxys:1725150; Wikipedia:Succimer
G
Aasdhppt
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AASDHPPT mRNA
CTD
PMID:26378955
NCBI chr 8:1,453,226...1,463,990
Ensembl chr 8:1,452,282...1,463,966
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCB1 mRNA
CTD
PMID:26378955
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions increases transport
EXP ISO
ABCC2 protein affects the reaction [Succimer binds to and results in increased secretion of [Mercuric Chloride binds to Cysteine]]; ABCC2 protein binds to and results in increased secretion of [Succimer binds to [Mercuric Chloride binds to Cysteine]] ABCC2 results in increased transport of Succimer metabolite ABCC2 protein results in increased transport of Succimer metabolite
CTD
PMID:17940195 PMID:18511429 PMID:19063911
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abce1
ATP binding cassette subfamily E member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCE1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCE1 mRNA
CTD
PMID:26378955
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCG1 mRNA
CTD
PMID:26378955
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Ablim1
actin-binding LIM protein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABLIM1 mRNA
CTD
PMID:26378955
NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969
G
Abtb2
ankyrin repeat and BTB domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ABTB2 mRNA
CTD
PMID:21641980
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
G
Acaa1a
acetyl-CoA acyltransferase 1A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ACAA1A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACAA1A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA
CTD
PMID:21641980
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Acod1
aconitate decarboxylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACOD1 mRNA
CTD
PMID:21641980
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Acsl4
acyl-CoA synthetase long-chain family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACSL4 mRNA
CTD
PMID:21641980
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Actc1
actin, alpha, cardiac muscle 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACTC1 mRNA
CTD
PMID:26378955
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
G
Actg2
actin gamma 2, smooth muscle
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACTG2 mRNA
CTD
PMID:26378955
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
G
Acy1
aminoacylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACY1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACY1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Acy3
aminoacylase 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACY3 mRNA
CTD
PMID:26378955
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
G
Adam28
ADAM metallopeptidase domain 28
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM28 mRNA
CTD
PMID:26378955
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
G
Adam8
ADAM metallopeptidase domain 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM8 mRNA
CTD
PMID:26378955
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAMTS1 mRNA
CTD
PMID:26378955
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts10
ADAM metallopeptidase with thrombospondin type 1 motif, 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS10 mRNA
CTD
PMID:26378955
NCBI chr 7:14,331,659...14,361,620
Ensembl chr 7:14,331,745...14,361,620
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS5 mRNA
CTD
PMID:26378955
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Adat1
adenosine deaminase, tRNA-specific 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAT1 mRNA
CTD
PMID:26378955
NCBI chr19:39,918,083...39,956,886
Ensembl chr19:39,918,227...39,956,883
G
Add3
adducin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ADD3 mRNA
CTD
PMID:21641980
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adm
adrenomedullin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADM mRNA
CTD
PMID:21641980
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora2b
adenosine A2B receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADORA2B mRNA
CTD
PMID:21641980
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Aebp2
AE binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AEBP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AEBP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:173,527,881...173,566,033
Ensembl chr 4:173,528,344...173,593,100
G
Afp
alpha-fetoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AFP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AFP mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agap1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGAP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGAP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958
G
Agfg2
ArfGAP with FG repeats 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGFG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGFG2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:19,012,228...19,048,433
Ensembl chr12:19,012,258...19,048,421
G
Agmo
alkylglycerol monooxygenase
multiple interactions decreases expression
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGMO mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGMO mRNA Succimer results in decreased expression of AGMO mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
G
Agt
angiotensinogen
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGT mRNA
CTD
PMID:26378955
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahnak
AHNAK nucleoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AHNAK mRNA
CTD
PMID:21641980
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Ahnak2
AHNAK nucleoprotein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AHNAK2 mRNA
CTD
PMID:21641980
NCBI chr 6:131,830,668...131,876,311
G
Aif1l
allograft inflammatory factor 1-like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AIF1L mRNA
CTD
PMID:26378955
NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023
G
Akap9
A-kinase anchoring protein 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AKAP9 mRNA
CTD
PMID:21641980
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in decreased expression of AKT1 protein]
CTD
PMID:31163222
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aktip
AKT interacting protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AKTIP mRNA
CTD
PMID:26378955
NCBI chr19:15,866,811...15,877,123
Ensembl chr19:15,866,928...15,886,663
G
Alad
aminolevulinate dehydratase
multiple interactions increases activity
ISO EXP
[diphenyldiselenide co-treated with Succimer] inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]; Succimer inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein] Succimer inhibits the reaction [arsenite results in decreased activity of ALAD protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein] Succimer results in increased activity of ALAD protein
CTD
PMID:9559101 PMID:15202869 PMID:15331134 PMID:17188940
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alcam
activated leukocyte cell adhesion molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALCAM mRNA
CTD
PMID:21641980
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ALDH1L1 mRNA
CTD
PMID:21641980
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Alg6
ALG6, alpha-1,3-glucosyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALG6 mRNA
CTD
PMID:21641980
NCBI chr 5:114,404,972...114,454,440
Ensembl chr 5:114,405,010...114,454,439
G
Alkbh8
alkB homolog 8, tRNA methyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ALKBH8 mRNA
CTD
PMID:26378955
NCBI chr 6:378,779...449,382
Ensembl chr 6:378,100...452,165
G
Alpg
alkaline phosphatase, germ cell
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ALPG mRNA
CTD
PMID:26378955
NCBI chr 9:87,748,721...87,761,500
Ensembl chr 9:87,753,648...87,757,836
G
Ampd3
adenosine monophosphate deaminase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AMPD3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AMPD3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Amz1
archaelysin family metallopeptidase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AMZ1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AMZ1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
G
Anapc1
anaphase promoting complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANAPC1 mRNA
CTD
PMID:21641980
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
G
Angpt2
angiopoietin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANGPT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ANGPT2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Angptl2
angiopoietin-like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ANGPTL2 mRNA
CTD
PMID:21641980
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
Ank3
ankyrin 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANK3 mRNA
CTD
PMID:26378955
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Ankmy1
ankyrin repeat and MYND domain containing 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANKMY1 mRNA
CTD
PMID:26378955
NCBI chr 9:93,423,664...93,476,651
Ensembl chr 9:93,423,963...93,477,236
G
Ankrd12
ankyrin repeat domain 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD12 mRNA
CTD
PMID:21641980
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
G
Ankrd26
ankyrin repeat domain containing 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD26 mRNA
CTD
PMID:21641980
NCBI chr 4:151,670,604...151,740,032
Ensembl chr 4:151,672,037...151,739,968
G
Ankrd37
ankyrin repeat domain 37
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD37 mRNA
CTD
PMID:21641980
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Ankrd44
ankyrin repeat domain 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD44 mRNA
CTD
PMID:21641980
NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508
G
Anpep
alanyl aminopeptidase, membrane
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANPEP mRNA
CTD
PMID:26378955
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Aox1
aldehyde oxidase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AOX1 mRNA
CTD
PMID:26378955
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Apobec1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of APOBEC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOBEC1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
G
Apoc2
apolipoprotein C2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOC2 mRNA
CTD
PMID:26378955
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoh
apolipoprotein H
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOH mRNA
CTD
PMID:21641980
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
G
Apol9a
apolipoprotein L9a
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOL9A mRNA
CTD
PMID:21641980
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
G
Aqp11
aquaporin 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of AQP11 mRNA
CTD
PMID:21641980
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
G
Arap3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARAP3 mRNA
CTD
PMID:26378955
NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555
G
Arf2
ADP-ribosylation factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARF2 mRNA
CTD
PMID:21641980
NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659
G
Arfgef3
ARFGEF family member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARFGEF3 mRNA
CTD
PMID:21641980
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
G
Arg2
arginase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARG2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ARG2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgap18
Rho GTPase activating protein 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA
CTD
PMID:21641980
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgef6
Rac/Cdc42 guanine nucleotide exchange factor 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGEF6 mRNA
CTD
PMID:21641980
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
G
Arpc2
actin related protein 2/3 complex, subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPC2 mRNA
CTD
PMID:21641980
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
G
Arpp19
cAMP-regulated phosphoprotein 19
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPP19 mRNA
CTD
PMID:21641980
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
G
Arrdc4
arrestin domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARRDC4 mRNA
CTD
PMID:21641980
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Ash1l
ASH1 like histone lysine methyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ASH1L mRNA
CTD
PMID:26378955
NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055
G
Asph
aspartate-beta-hydroxylase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ASPH mRNA
CTD
PMID:26378955
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
G
Atad2
ATPase family, AAA domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA
CTD
PMID:21641980
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atad5
ATPase family, AAA domain containing 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD5 mRNA
CTD
PMID:21641980
NCBI chr10:65,070,682...65,118,489
Ensembl chr10:65,070,689...65,117,845
G
Atf2
activating transcription factor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATF2 mRNA
CTD
PMID:26378955
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atp11c
ATPase phospholipid transporting 11C
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP11C mRNA
CTD
PMID:26378955
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp13a3
ATPase 13A3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP13A3 mRNA
CTD
PMID:26378955
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP1B1 mRNA
CTD
PMID:26378955
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP2B1 mRNA
CTD
PMID:21641980
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Atp6v0d2
ATPase H+ transporting V0 subunit D2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP6V0D2 mRNA
CTD
PMID:21641980
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
G
Atp7a
ATPase copper transporting alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP7A mRNA
CTD
PMID:26378955
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp8a1
ATPase phospholipid transporting 8A1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATP8A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP8A1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Atrx
ATRX, chromatin remodeler
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ATRX mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATRX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
G
Atxn1
ataxin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATXN1 mRNA
CTD
PMID:21641980
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
G
Atxn3
ataxin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATXN3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATXN3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:121,072,228...121,107,902
Ensembl chr 6:121,074,448...121,107,902
G
B3galt4
Beta-1,3-galactosyltransferase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of B3GALT4 mRNA
CTD
PMID:21641980
NCBI chr20:4,936,089...4,937,664
Ensembl chr20:4,931,768...4,938,315
G
B4galt5
beta-1,4-galactosyltransferase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of B4GALT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of B4GALT5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
G
Bak1
BCL2-antagonist/killer 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAK1 mRNA
CTD
PMID:26378955
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA]
CTD
PMID:31163222 PMID:32402895
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Baz1a
bromodomain adjacent to zinc finger domain, 1A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ1A mRNA
CTD
PMID:26378955
NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459
G
Baz2b
bromodomain adjacent to zinc finger domain, 2B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ2B mRNA
CTD
PMID:26378955
NCBI chr 3:44,384,282...44,681,619
Ensembl chr 3:44,385,474...44,592,908
G
Bbox1
gamma-butyrobetaine hydroxylase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BBOX1 mRNA
CTD
PMID:26378955
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
G
Bbs9
Bardet-Biedl syndrome 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BBS9 mRNA
CTD
PMID:21641980
NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA]
CTD
PMID:32402895
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bcl6b
BCL6B, transcription repressor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL6B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL6B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
G
Bcl7a
BAF chromatin remodeling complex subunit BCL7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCL7A mRNA
CTD
PMID:21641980
NCBI chr12:33,211,978...33,243,903
Ensembl chr12:33,223,931...33,243,886
G
Bclaf1
BCL2-associated transcription factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCLAF1 mRNA
CTD
PMID:21641980
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bco2
beta-carotene oxygenase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCO2 mRNA
CTD
PMID:26378955
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BIRC3 mRNA
CTD
PMID:26378955
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blm
BLM RecQ like helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BLM mRNA
CTD
PMID:21641980
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
G
Blvrb
biliverdin reductase B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BLVRB mRNA
CTD
PMID:21641980
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BPNT2 mRNA
CTD
PMID:26378955
NCBI chr 5:17,775,684...17,802,570
Ensembl chr 5:17,772,608...17,802,570
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRAF mRNA
CTD
PMID:26378955
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Brca1
BRCA1, DNA repair associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRCA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRCA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BRCA2 mRNA
CTD
PMID:26378955
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Brd8
bromodomain containing 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRD8 mRNA
CTD
PMID:21641980
NCBI chr18:26,204,892...26,229,999
Ensembl chr18:26,181,732...26,229,884
G
Brwd1
bromodomain and WD repeat domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRWD1 mRNA
CTD
PMID:21641980
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
G
Btg1
BTG anti-proliferation factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BTG1 mRNA
CTD
PMID:21641980
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG2 mRNA
CTD
PMID:21641980
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg3
BTG anti-proliferation factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG3 mRNA
CTD
PMID:21641980
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
C1galt1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C1GALT1 mRNA
CTD
PMID:26378955
NCBI chr 4:35,930,981...35,966,100
Ensembl chr 4:35,928,104...35,961,831
G
C3
complement C3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C3 mRNA
CTD
PMID:26378955
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1A mRNA
CTD
PMID:26378955
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1B mRNA
CTD
PMID:26378955
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Cadps
calcium dependent secretion activator
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CADPS mRNA
CTD
PMID:26378955
NCBI chr15:12,289,803...12,742,786
Ensembl chr15:12,290,262...12,742,779
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAMK1D mRNA
CTD
PMID:21641980
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAMK2D mRNA
CTD
PMID:21641980
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Cand1
cullin-associated and neddylation-dissociated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAND1 mRNA
CTD
PMID:21641980
NCBI chr 7:54,681,114...54,719,002
Ensembl chr 7:54,680,900...54,718,993
G
Canx
calnexin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CANX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CANX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Capn3
calpain 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN3 mRNA
CTD
PMID:26378955
NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858
G
Capn7
calpain 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAPN7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
G
Car13
carbonic anhydrase 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAR13 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CAR13 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525
G
Cask
calcium/calmodulin dependent serine protein kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASK mRNA
CTD
PMID:21641980
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp1
caspase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP1 mRNA
CTD
PMID:26378955
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP12 mRNA
CTD
PMID:26378955
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]
CTD
PMID:31163222
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP4 mRNA
CTD
PMID:26378955
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp8ap2
caspase 8 associated protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
G
Cast
calpastatin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAST mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAST mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Succimer promotes the reaction [Thioctic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]]; Thioctic Acid promotes the reaction [Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]]
CTD
PMID:15998567 PMID:31163222 PMID:32402895
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbfa2t2
CBFA2/RUNX1 partner transcriptional co-repressor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CBFA2T2 mRNA
CTD
PMID:26378955
NCBI chr 3:142,936,945...143,043,205
Ensembl chr 3:142,936,985...143,043,197
G
Cblb
Cbl proto-oncogene B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of CBLB mRNA
CTD
PMID:26378955
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
Ccdc117
coiled-coil domain containing 117
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC117 mRNA
CTD
PMID:21641980
NCBI chr14:80,399,236...80,409,824
Ensembl chr14:80,400,294...80,409,659
G
Ccdc88a
coiled coil domain containing 88A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC88A mRNA
CTD
PMID:21641980
NCBI chr14:103,104,091...103,256,112
Ensembl chr14:103,103,513...103,252,368
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL22 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL22 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccl9
C-C motif chemokine ligand 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccn1
cellular communication network factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCN1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN1 mRNA
CTD
PMID:26378955
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN2 mRNA
CTD
PMID:26378955
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccng2
cyclin G2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA
CTD
PMID:21641980
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnt2
cyclin T2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNT2 mRNA
CTD
PMID:21641980
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
G
Ccny
cyclin Y
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNY mRNA
CTD
PMID:21641980
NCBI chr17:57,385,002...57,512,860
Ensembl chr17:57,384,176...57,522,378
G
Ccr1
C-C motif chemokine receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCR1 mRNA
CTD
PMID:21641980
NCBI chr 8:123,556,286...123,561,841
G
Ccrl2
C-C motif chemokine receptor like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCRL2 mRNA
CTD
PMID:21641980
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
G
Cd109
CD109 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD109 mRNA
CTD
PMID:21641980
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd200r1l
CD200 receptor 1-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD200R4 mRNA
CTD
PMID:21641980
NCBI chr11:55,842,632...55,860,914
Ensembl chr11:55,842,634...55,885,680
G
Cd209d
CD209d molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD209 mRNA
CTD
PMID:26378955
NCBI chr12:1,891,109...1,897,559
Ensembl chr12:1,891,113...1,901,171
G
Cd24
CD24 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD24A mRNA
CTD
PMID:21641980
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd274
CD274 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD274 mRNA
CTD
PMID:21641980
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd276
Cd276 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD276 mRNA
CTD
PMID:21641980
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
G
Cd36
CD36 molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD36 mRNA
CTD
PMID:26378955
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD40 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD40 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd5l
Cd5 molecule-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD5L mRNA
CTD
PMID:21641980
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cd74
CD74 molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CD74 mRNA
CTD
PMID:26378955
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd80
Cd80 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD80 mRNA
CTD
PMID:21641980
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD83 mRNA
CTD
PMID:21641980
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd86
CD86 molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD86 mRNA
CTD
PMID:26378955
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cd93
CD93 molecule
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD93 mRNA
CTD
PMID:21641980
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
G
Cda
cytidine deaminase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDA mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
G
Cdadc1
cytidine and dCMP deaminase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDADC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDADC1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:33,726,590...33,755,611
Ensembl chr15:33,723,435...33,755,576
G
Cdc42bpa
CDC42 binding protein kinase alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDC42BPA mRNA
CTD
PMID:26378955
NCBI chr13:91,683,775...91,903,732
Ensembl chr13:91,684,007...91,903,732
G
Cdc42ep2
CDC42 effector protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDC42EP2 mRNA
CTD
PMID:21641980
NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897
G
Cdc6
cell division cycle 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC6 mRNA
CTD
PMID:21641980
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdc7
cell division cycle 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDC7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
G
Cdh10
cadherin 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDH10 mRNA
CTD
PMID:26378955
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
G
Cdk12
cyclin-dependent kinase 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDK12 mRNA
CTD
PMID:21641980
NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888 Ensembl chr10:83,201,211...83,280,888
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDKN1A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDKN1A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdo1
cysteine dioxygenase type 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDO1 mRNA
CTD
PMID:26378955
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
G
Cds2
CDP-diacylglycerol synthase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDS2 mRNA
CTD
PMID:21641980
NCBI chr 3:119,514,963...119,553,555
Ensembl chr 3:119,515,000...119,553,541
G
Cebpd
CCAAT/enhancer binding protein delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CEBPD mRNA
CTD
PMID:21641980
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
G
Celf2
CUGBP, Elav-like family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CELF2 mRNA
CTD
PMID:21641980
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
G
Cenpe
centromere protein E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPE mRNA
CTD
PMID:21641980
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Cenpj
centromere protein J
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPJ mRNA
CTD
PMID:21641980
NCBI chr15:30,627,206...30,690,384
Ensembl chr15:30,627,224...30,686,791
G
Cep170
centrosomal protein 170
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CEP170 mRNA
CTD
PMID:21641980
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Cept1
choline/ethanolamine phosphotransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CEPT1 mRNA
CTD
PMID:26378955
NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578
G
Cerk
ceramide kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CERK mRNA
CTD
PMID:21641980
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
G
Cers4
ceramide synthase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CERS4 mRNA
CTD
PMID:21641980
NCBI chr12:2,851,784...2,890,244
Ensembl chr12:2,851,784...2,886,828
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Chd4
chromodomain helicase DNA binding protein 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHD4 mRNA
CTD
PMID:26378955
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chd9
chromodomain helicase DNA binding protein 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHD9 mRNA
CTD
PMID:21641980
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
G
Chek1
checkpoint kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHEK1 mRNA
CTD
PMID:21641980
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chit1
chitinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CHIT1 mRNA
CTD
PMID:21641980
NCBI chr13:45,565,841...45,613,593
Ensembl chr13:45,593,845...45,613,592
G
Chka
choline kinase alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHKA mRNA
CTD
PMID:21641980
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chn1
chimerin 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CHN1 mRNA
CTD
PMID:26378955
NCBI chr 3:58,509,822...58,676,462
Ensembl chr 3:58,510,536...58,676,490
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHUK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHUK mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Cldn12
claudin 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLDN12 mRNA
CTD
PMID:21641980
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
G
Clec10a
C-type lectin domain containing 10A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC10A mRNA
CTD
PMID:21641980
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
G
Clec4a
C-type lectin domain family 4, member A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4N mRNA
CTD
PMID:21641980
NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402
G
Clec4a3
C-type lectin domain family 4, member A3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLEC4A3 mRNA
CTD
PMID:21641980
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Clec4e
C-type lectin domain family 4, member E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4E mRNA
CTD
PMID:21641980
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
G
Clec7a
C-type lectin domain containing 7A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CLEC7A mRNA
CTD
PMID:26378955
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Clk1
CDC-like kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLK1 mRNA
CTD
PMID:21641980
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
G
Clmn
calmin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLMN mRNA
CTD
PMID:21641980
NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLPX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CLPX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
G
Clspn
claspin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLSPN mRNA
CTD
PMID:21641980
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Clta
clathrin, light chain A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTA mRNA
CTD
PMID:21641980
NCBI chr 5:58,244,253...58,263,480
Ensembl chr 5:58,245,442...58,263,472
G
Cltc
clathrin heavy chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTC mRNA
CTD
PMID:21641980
NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737
G
Clu
clusterin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLU mRNA
CTD
PMID:21641980
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmpk2
cytidine/uridine monophosphate kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CMPK2 mRNA
CTD
PMID:21641980
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
G
Cnnm3
cyclin and CBS domain divalent metal cation transport mediator 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNNM3 mRNA
CTD
PMID:21641980
NCBI chr 9:38,755,374...38,770,740
Ensembl chr 9:38,755,390...38,770,740
G
Cnot4
CCR4-NOT transcription complex, subunit 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNOT4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CNOT4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:63,712,770...63,814,355
Ensembl chr 4:63,712,770...63,814,360
G
Cnot7
CCR4-NOT transcription complex, subunit 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CNOT7 mRNA
CTD
PMID:26378955
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
G
Col14a1
collagen type XIV alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL14A1 mRNA
CTD
PMID:21641980
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col18a1
collagen type XVIII alpha 1 chain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL18A1 mRNA
CTD
PMID:26378955
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col3a1
collagen type III alpha 1 chain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL3A1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL3A1 mRNA
CTD
PMID:26378955
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col5a1
collagen type V alpha 1 chain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL5A1 mRNA
CTD
PMID:26378955
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col7a1
collagen type VII alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL7A1 mRNA
CTD
PMID:21641980
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Col8a1
collagen type VIII alpha 1 chain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL8A1 mRNA
CTD
PMID:21641980
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Colec12
collectin sub-family member 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COLEC12 mRNA
CTD
PMID:26378955
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Cox5b
cytochrome c oxidase subunit 5B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COX5B mRNA
CTD
PMID:26378955
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
G
Cp
ceruloplasmin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CP mRNA
CTD
PMID:26378955
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpa4
carboxypeptidase A4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CPA4 mRNA
CTD
PMID:26378955
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
G
Cpd
carboxypeptidase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPD mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPD mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
G
Cpn1
carboxypeptidase N subunit 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPN1 mRNA
CTD
PMID:26378955
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
G
Cpne2
copine 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPNE2 mRNA
CTD
PMID:21641980
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
G
Crebbp
CREB binding protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CREBBP mRNA
CTD
PMID:26378955
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crim1
cysteine rich transmembrane BMP regulator 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CRIM1 mRNA
CTD
PMID:26378955
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
G
Csad
cysteine sulfinic acid decarboxylase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSAD mRNA
CTD
PMID:26378955
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf1
colony stimulating factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CSF1 mRNA
CTD
PMID:26378955
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSF3 mRNA
CTD
PMID:21641980
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csgalnact1
chondroitin sulfate N-acetylgalactosaminyltransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT1 mRNA
CTD
PMID:26378955
NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319
G
Csgalnact2
chondroitin sulfate N-acetylgalactosaminyltransferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSGALNACT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:151,271,774...151,308,856
Ensembl chr 4:151,277,645...151,308,839
G
Csn3
casein kappa
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSN3 mRNA
CTD
PMID:21641980
NCBI chr14:20,154,032...20,160,585
Ensembl chr14:20,154,032...20,160,587
G
Csrp2
cysteine and glycine-rich protein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSRP2 mRNA
CTD
PMID:26378955
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
G
Cst3
cystatin C
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CST3 mRNA
CTD
PMID:26378955
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cst7
cystatin F
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CST7 mRNA
CTD
PMID:26378955
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
G
Cstf3
cleavage stimulation factor subunit 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSTF3 mRNA
CTD
PMID:21641980
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
G
Ctcf
CCCTC-binding factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTCF mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTCF mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
G
Ctdspl2
CTD small phosphatase like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTDSPL2 mRNA
CTD
PMID:21641980
NCBI chr 3:108,915,263...108,970,620
Ensembl chr 3:108,915,280...108,967,227
G
Cth
cystathionine gamma-lyase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CTH mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTH mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctsb
cathepsin B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSB mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTSB mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsf
cathepsin F
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CTSF mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525
G
Ctsh
cathepsin H
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSH mRNA
CTD
PMID:26378955
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
Ctsk
cathepsin K
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSK mRNA
CTD
PMID:26378955
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Ctss
cathepsin S
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSS mRNA
CTD
PMID:26378955
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cttnbp2nl
CTTNBP2 N-terminal like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTTNBP2NL mRNA
CTD
PMID:21641980
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
G
Cul3
cullin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUL3 mRNA
CTD
PMID:21641980
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cux1
cut-like homeobox 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUX1 mRNA
CTD
PMID:21641980
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Cwc22
CWC22 spliceosome associated protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CWC22 mRNA
CTD
PMID:21641980
NCBI chr 3:62,815,230...62,864,269
Ensembl chr 3:62,802,045...62,864,228
G
Cx3cr1
C-X3-C motif chemokine receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CX3CR1 mRNA
CTD
PMID:21641980
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL11 mRNA
CTD
PMID:26378955
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl13
C-X-C motif chemokine ligand 13
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL13 mRNA
CTD
PMID:26378955
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl16
C-X-C motif chemokine ligand 16
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CXCL16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CXCL16 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL1 mRNA
CTD
PMID:26378955
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyb5r4
cytochrome b5 reductase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYB5R4 mRNA
CTD
PMID:26378955
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
G
Cybb
cytochrome b-245 beta chain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYBB mRNA
CTD
PMID:26378955
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP1A1 mRNA
CTD
PMID:26378955
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Succimer results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp20a1
cytochrome P450, family 20, subfamily a, polypeptide 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP20A1 mRNA
CTD
PMID:26378955
NCBI chr 9:61,755,804...61,805,123
Ensembl chr 9:61,755,790...61,805,123
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2B10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2B10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2C55 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2C55 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Cyp2s1
cytochrome P450, family 2, subfamily s, polypeptide 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2S1 mRNA
CTD
PMID:26378955
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4B1 mRNA
CTD
PMID:26378955
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP4F39 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4F39 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp4v3
cytochrome P450, family 4, subfamily v, polypeptide 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4V3 mRNA
CTD
PMID:26378955
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
G
Cyp51
cytochrome P450, family 51
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP7B1 mRNA
CTD
PMID:26378955
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyrib
CYFIP related Rac1 interactor B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYRIB mRNA
CTD
PMID:21641980
NCBI chr 7:95,633,876...95,760,588
Ensembl chr 7:95,633,876...95,697,686
G
Daam1
dishevelled associated activator of morphogenesis 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DAAM1 mRNA
CTD
PMID:21641980
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Dab2
DAB adaptor protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DAB2 mRNA
CTD
PMID:21641980
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCBLD2 mRNA
CTD
PMID:21641980
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
G
Dcstamp
dendrocyte expressed seven transmembrane protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCSTAMP mRNA
CTD
PMID:21641980
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
G
Ddhd1
DDHD domain containing 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DDHD1 mRNA
CTD
PMID:26378955
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDIT3 mRNA
CTD
PMID:21641980
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddx46
DEAD-box helicase 46
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX46 mRNA
CTD
PMID:21641980
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
G
Ddx50
DExD-box helicase 50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX50 mRNA
CTD
PMID:21641980
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Deptor
DEP domain containing MTOR-interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DEPTOR mRNA
CTD
PMID:21641980
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Dhcr24
24-dehydrocholesterol reductase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DHCR24 mRNA
CTD
PMID:26378955
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhx58
DEXH-box helicase 58
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DHX58 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DHX58 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Dhx9
DExH-box helicase 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DHX9 mRNA
CTD
PMID:21641980
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dkc1
dyskerin pseudouridine synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DKC1 mRNA
CTD
PMID:21641980
G
Dlat
dihydrolipoamide S-acetyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DLAT mRNA
CTD
PMID:21641980
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
G
Dmpk
DM1 protein kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DMPK mRNA
CTD
PMID:26378955
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
G
Dnajc2
DnaJ heat shock protein family (Hsp40) member C2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC2 mRNA
CTD
PMID:21641980
NCBI chr 4:13,270,239...13,297,438
Ensembl chr 4:13,270,191...13,297,431
G
Dnajc21
DnaJ heat shock protein family (Hsp40) member C21
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC21 mRNA
CTD
PMID:26378955
NCBI chr 2:59,419,507...59,446,746
Ensembl chr 2:59,419,510...59,446,752
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC3 mRNA
CTD
PMID:21641980
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNAJC5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNAJC5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:168,621,905...168,656,570
Ensembl chr 3:168,621,969...168,655,935
G
Dnajc5b
DnaJ heat shock protein family (Hsp40) member C5 beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC5B mRNA
CTD
PMID:26378955
NCBI chr 2:101,973,726...102,066,275
Ensembl chr 2:101,973,793...102,066,275
G
Dnmt3l
DNA methyltransferase 3 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNMT3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNMT3L mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Dock10
dedicator of cytokinesis 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DOCK10 mRNA
CTD
PMID:21641980
NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:81,843,604...82,101,525
G
Dph3
diphthamide biosynthesis 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPH3 mRNA
CTD
PMID:26378955
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
G
Dph5
diphthamide biosynthesis 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DPH5 mRNA
CTD
PMID:21641980
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPYD mRNA
CTD
PMID:26378955
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dpys
dihydropyrimidinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DPYS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DPYS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
G
Dsc2
desmocollin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSC2 mRNA
CTD
PMID:26378955
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
G
Dscc1
DNA replication and sister chromatid cohesion 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DSCC1 mRNA
CTD
PMID:21641980
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
Dsg2
desmoglein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSG2 mRNA
CTD
PMID:26378955
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
G
Dtl
denticleless E3 ubiquitin protein ligase homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DTL mRNA
CTD
PMID:21641980
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
G
Dtx1
deltex E3 ubiquitin ligase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX1 mRNA
CTD
PMID:26378955
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
G
Dtx4
deltex E3 ubiquitin ligase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX4 mRNA
CTD
PMID:26378955
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Dusp1
dual specificity phosphatase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP1 mRNA
CTD
PMID:21641980
NCBI chr10:16,680,478...16,683,275
G
Dusp14
dual specificity phosphatase 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP14 mRNA
CTD
PMID:21641980
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
G
Dusp6
dual specificity phosphatase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP6 mRNA
CTD
PMID:21641980
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dzip3
DAZ interacting zinc finger protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DZIP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DZIP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353
G
E2f2
E2F transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F2 mRNA
CTD
PMID:21641980
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
G
E2f7
E2F transcription factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F7 mRNA
CTD
PMID:21641980
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
E2f8
E2F transcription factor 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F8 mRNA
CTD
PMID:21641980
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ect2
epithelial cell transforming 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ECT2 mRNA
CTD
PMID:21641980
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Edil3
EGF like repeats and discoidin domains 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EDIL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EDIL3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Eef1d
eukaryotic translation elongation factor 1 delta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EEF1D mRNA
CTD
PMID:21641980
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
G
Eeig2
EEIG family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EEIG2 mRNA
CTD
PMID:21641980
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
G
Efcab7
EF-hand calcium binding domain 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EFCAB7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EFCAB7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:114,525,403...114,576,130
Ensembl chr 5:114,525,167...114,576,129
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGFR mRNA
CTD
PMID:26378955
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egln3
egl-9 family hypoxia-inducible factor 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGLN3 mRNA
CTD
PMID:26378955
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Egr1
early growth response 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of EGR1 mRNA
CTD
PMID:26378955
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EGR2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EGR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EGR2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Egr3
early growth response 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGR3 mRNA
CTD
PMID:26378955
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehd1
EH-domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EHD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EHD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212
G
Ehd2
EH-domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EHD2 mRNA
CTD
PMID:26378955
NCBI chr 1:76,639,568...76,658,747
Ensembl chr 1:76,637,482...76,658,783
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EIF2AK2 mRNA
CTD
PMID:26378955
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S1 mRNA
CTD
PMID:21641980
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eif2s3y
eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S3Y mRNA
CTD
PMID:21641980
NCBI chr Y:869,654...889,341
Ensembl chr Y:869,689...889,340
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF3A mRNA
CTD
PMID:21641980
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
G
Ell2
elongation factor for RNA polymerase II 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ELL2 mRNA
CTD
PMID:21641980
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
G
Eloc
elongin C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOC mRNA
CTD
PMID:21641980
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890
G
Elovl6
ELOVL fatty acid elongase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOVL6 mRNA
CTD
PMID:21641980
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Endod1
endonuclease domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ENDOD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ENDOD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:11,209,113...11,238,507
Ensembl chr 8:11,211,110...11,238,892
G
Eno2
enolase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ENO2 mRNA
CTD
PMID:26378955
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ENPP2 mRNA
CTD
PMID:26378955
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EPB41L2 mRNA
CTD
PMID:21641980
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
G
Epha8
Eph receptor A8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPHA8 mRNA
CTD
PMID:21641980
NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399
G
Eps15
epidermal growth factor receptor pathway substrate 15
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EPS15 mRNA
CTD
PMID:26378955
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
G
Epsti1
epithelial stromal interaction 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPSTI1 mRNA
CTD
PMID:21641980
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
G
Erap1
endoplasmic reticulum aminopeptidase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERAP1 mRNA
CTD
PMID:26378955
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Erbb4
erb-b2 receptor tyrosine kinase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERBB4 mRNA
CTD
PMID:26378955
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ERN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ERN1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERO1A mRNA
CTD
PMID:26378955
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ESCO2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ESCO2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ESCO2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esd
esterase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ESD mRNA
CTD
PMID:21641980
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Esr1
estrogen receptor 1
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ESR1 protein]; Succimer inhibits the reaction [sodium arsenite results in decreased expression of ESR1 protein]
CTD
PMID:31163222 PMID:32402895
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Ets2
ETS proto-oncogene 2, transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ETS2 mRNA
CTD
PMID:21641980
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Eva1b
eva-1 homolog B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of EVA1B mRNA
CTD
PMID:21641980
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
G
Evi5
ecotropic viral integration site 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EVI5 mRNA
CTD
PMID:21641980
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Exo1
exonuclease 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EXO1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exosc1
exosome component 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXOSC1 mRNA
CTD
PMID:21641980
NCBI chr 1:240,734,777...240,745,431
Ensembl chr 1:240,734,773...240,745,438
G
Eya4
EYA transcriptional coactivator and phosphatase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EYA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EYA4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976
G
F13a1
coagulation factor XIII A1 chain
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of F13A1 mRNA
CTD
PMID:26378955
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of F3 mRNA
CTD
PMID:26378955
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fam13b
family with sequence similarity 13, member B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13B mRNA
CTD
PMID:21641980
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
G
Fam13c
family with sequence similarity 13, member C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13C mRNA
CTD
PMID:21641980
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam162a
family with sequence similarity 162, member A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAM162A mRNA
CTD
PMID:26378955
NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239
G
Fam199x
family with sequence similarity 199, X-linked
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM199X mRNA
CTD
PMID:21641980
NCBI chr X:100,384,230...100,419,935
Ensembl chr X:100,384,225...100,414,938
G
Fam20c
FAM20C, golgi associated secretory pathway kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAM20C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAM20C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
G
Fam76b
family with sequence similarity 76, member B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM76B mRNA
CTD
PMID:21641980
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
G
Fancb
FA complementation group B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FANCB mRNA
CTD
PMID:21641980
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
G
Far1
fatty acyl CoA reductase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAR1 mRNA
CTD
PMID:21641980
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbp1
fructose-bisphosphatase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FBP1 mRNA
CTD
PMID:26378955
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fbxo15
F-box protein 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FBXO15 mRNA
CTD
PMID:21641980
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
G
Fcgr3a
Fc gamma receptor 3A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FCGR4 mRNA
CTD
PMID:21641980
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Fez1
fasciculation and elongation protein zeta 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FEZ1 mRNA
CTD
PMID:26378955
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
G
Fgd2
FYVE, RhoGEF and PH domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,424,790...7,441,603
G
Fgd3
FYVE, RhoGEF and PH domain containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD3 mRNA
CTD
PMID:26378955
NCBI chr17:15,324,848...15,387,271
Ensembl chr17:15,336,837...15,385,712
G
Fgd4
FYVE, RhoGEF and PH domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972
G
Fgf1
fibroblast growth factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGF1 mRNA
CTD
PMID:26378955
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fhit
fragile histidine triad diadenosine triphosphatase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FHIT mRNA
CTD
PMID:26378955
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
G
Fip1l1
factor interacting with PAPOLA and CPSF1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FIP1L1 mRNA
CTD
PMID:21641980
NCBI chr14:33,615,210...33,675,742
Ensembl chr14:33,617,720...33,675,708
G
Fli1
Fli-1 proto-oncogene, ETS transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FLI1 mRNA
CTD
PMID:21641980
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
G
Fmn1
formin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FMN1 mRNA
CTD
PMID:21641980
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
G
Fn1
fibronectin 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FN1 mRNA
CTD
PMID:26378955
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL1 mRNA
CTD
PMID:21641980
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL2 mRNA
CTD
PMID:21641980
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxp1
forkhead box P1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FOXP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FOXP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Frmd4b
FERM domain containing 4B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FRMD4B mRNA
CTD
PMID:21641980
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
G
Fscn1
fascin actin-bundling protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FSCN1 mRNA
CTD
PMID:21641980
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in decreased expression of FSHB protein]
CTD
PMID:31163222
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FTH1 mRNA
CTD
PMID:26378955
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Fubp1
far upstream element binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUBP1 mRNA
CTD
PMID:21641980
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fus
Fus RNA binding protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FUS mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
G
Fut11
fucosyltransferase 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUT11 mRNA
CTD
PMID:21641980
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
G
Fxyd2
FXYD domain-containing ion transport regulator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FXYD2 mRNA
CTD
PMID:21641980
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FYCO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FYCO1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FYN mRNA
CTD
PMID:26378955
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Fzd10
frizzled class receptor 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD10 mRNA
CTD
PMID:26378955
NCBI chr12:28,098,371...28,101,566
Ensembl chr12:28,098,371...28,101,566
G
Fzd7
frizzled class receptor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FZD7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
G2e3
G2/M-phase specific E3 ubiquitin protein ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of G2E3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of G2E3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
G
Gabpb1
GA binding protein transcription factor subunit beta 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GABPB1 mRNA
CTD
PMID:21641980
NCBI chr 3:113,879,972...113,924,742
Ensembl chr 3:113,879,973...113,923,696
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45A mRNA
CTD
PMID:21641980
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45B mRNA
CTD
PMID:21641980
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of GALNT1 mRNA
CTD
PMID:26378955
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
G
Galnt7
polypeptide N-acetylgalactosaminyltransferase 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GALNT7 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GALNT7 mRNA
CTD
PMID:26378955
NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690
G
Garin5a
golgi associated RAB2 interactor 5A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GARIN5A mRNA
CTD
PMID:21641980
NCBI chr 1:94,988,959...94,995,971
Ensembl chr 1:94,988,613...94,993,539
G
Gas5
growth arrest specific 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS5 mRNA
CTD
PMID:21641980
NCBI chr13:73,303,611...73,306,932
G
Gas6
growth arrest specific 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GAS6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
G
Gask1b
golgi associated kinase 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GASK1B mRNA
CTD
PMID:21641980
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
G
Gbp1
guanylate binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP1 mRNA
CTD
PMID:21641980
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp6
guanylate binding protein family member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP6 mRNA
CTD
PMID:21641980
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gca
grancalcin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCA mRNA
CTD
PMID:26378955
NCBI chr 3:47,297,320...47,329,913
Ensembl chr 3:47,297,383...47,328,581
G
Gch1
GTP cyclohydrolase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLC mRNA
CTD
PMID:26378955
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gda
guanine deaminase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GDA mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gfod1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GFOD1 mRNA
CTD
PMID:21641980
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GGT1 mRNA
CTD
PMID:26378955
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gigyf2
GRB10 interacting GYF protein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GIGYF2 mRNA
CTD
PMID:26378955
NCBI chr 9:88,001,212...88,127,040
Ensembl chr 9:88,001,301...88,125,715
G
Gja1
gap junction protein, alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GJA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glg1
golgi glycoprotein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLG1 mRNA
CTD
PMID:26378955
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
G
Gli3
GLI family zinc finger 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GLI3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLI3 mRNA
CTD
PMID:26378955
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
G
Glipr1
GLI pathogenesis-related 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLIPR1 mRNA
CTD
PMID:26378955
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glrx
glutaredoxin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GLRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLRX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gmnn
geminin, DNA replication inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMNN mRNA
CTD
PMID:21641980
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gmps
guanine monophosphate synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMPS mRNA
CTD
PMID:21641980
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
G
Gna13
G protein subunit alpha 13
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNA13 mRNA
CTD
PMID:26378955
NCBI chr10:94,337,939...94,370,774
Ensembl chr10:94,337,725...94,370,774
G
Gnai2
G protein subunit alpha i2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAI2 mRNA
CTD
PMID:26378955
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnaq
G protein subunit alpha q
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAQ mRNA
CTD
PMID:26378955
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
G
Gng4
G protein subunit gamma 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GNG4 mRNA
CTD
PMID:21641980
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
G
Golga4
golgin A4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GOLGA4 mRNA
CTD
PMID:21641980
NCBI chr 8:118,208,200...118,285,003
G
Gpatch4
G patch domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPATCH4 mRNA
CTD
PMID:21641980
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
G
Gpbp1
GC-rich promoter binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPBP1 mRNA
CTD
PMID:21641980
NCBI chr 2:43,023,504...43,091,146
Ensembl chr 2:43,023,504...43,090,907
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GPD2 mRNA
CTD
PMID:26378955
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpr150
G protein-coupled receptor 150
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR150 mRNA
CTD
PMID:21641980
NCBI chr 2:5,546,304...5,550,889
Ensembl chr 2:5,548,578...5,550,714
G
Gpr155
G protein-coupled receptor 155
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPR155 mRNA
CTD
PMID:21641980
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
G
Gpr84
G protein-coupled receptor 84
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR84 mRNA
CTD
PMID:21641980
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
G
Gpr85
G protein-coupled receptor 85
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR85 mRNA
CTD
PMID:21641980
NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein]
CTD
PMID:32402895
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gramd1b
GRAM domain containing 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAMD1B mRNA
CTD
PMID:21641980
NCBI chr 8:40,654,492...40,893,869
Ensembl chr 8:40,659,182...40,893,925
G
Grap
GRB2-related adaptor protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAP mRNA
CTD
PMID:21641980
NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056
G
Grcc10
gene rich cluster, C10 gene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GRCC10 mRNA
CTD
PMID:21641980
NCBI chr 4:157,551,276...157,552,924
G
Gsap
gamma-secretase activating protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA
CTD
PMID:21641980
NCBI chr 4:13,813,046...13,907,875
Ensembl chr 4:13,813,046...13,907,814
G
Gsg1
germ cell associated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSG1 mRNA
CTD
PMID:21641980
NCBI chr 4:168,090,773...168,107,039
Ensembl chr 4:168,090,776...168,107,039
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GSK3B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GSN mRNA
CTD
PMID:26378955
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gtf3c2
general transcription factor IIIC subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GTF3C2 mRNA
CTD
PMID:21641980
NCBI chr 6:25,196,439...25,221,338
Ensembl chr 6:25,197,268...25,220,490
G
Gucy1b1
guanylate cyclase 1 soluble subunit beta 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GUCY1B1 mRNA
CTD
PMID:26378955
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
G
H1f2
H1.2 linker histone, cluster member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H1F2 mRNA
CTD
PMID:21641980
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H3f3b
H3.3 histone B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of H3F3B mRNA
CTD
PMID:21641980
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709
G
Haghl
hydroxyacylglutathione hydrolase-like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HAGHL mRNA
CTD
PMID:26378955
NCBI chr10:14,804,957...14,809,495
Ensembl chr10:14,804,997...14,807,665
G
Hao1
hydroxyacid oxidase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HAO1 mRNA
CTD
PMID:21641980
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
G
Haus6
HAUS augmin like complex subunit 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAUS6 mRNA
CTD
PMID:21641980
NCBI chr 5:101,116,532...101,156,396
Ensembl chr 5:101,119,300...101,153,124
G
Havcr2
hepatitis A virus cellular receptor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAVCR2 mRNA
CTD
PMID:21641980
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hbe1
hemoglobin subunit epsilon 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HBB-Y mRNA
CTD
PMID:26378955
NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391
G
Hbegf
heparin-binding EGF-like growth factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HBEGF mRNA
CTD
PMID:21641980
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hdac9
histone deacetylase 9
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HDAC9 mRNA
CTD
PMID:26378955
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Hdc
histidine decarboxylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HDC mRNA
CTD
PMID:21641980
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HECTD1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HECTD1 mRNA
CTD
PMID:26378955
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
G
Hells
helicase, lymphoid specific
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELLS mRNA
CTD
PMID:21641980
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Helz
helicase with zinc finger
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELZ mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HELZ mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HERPUD1 mRNA
CTD
PMID:26378955
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hfe
homeostatic iron regulator
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HFE mRNA
CTD
PMID:26378955
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hip1
huntingtin interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725
G
Hist1h2bc
histone cluster 1, H2bc
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2BC4 mRNA
CTD
PMID:21641980
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hist1h4m
histone cluster 1, H4m
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H4C1 mRNA
CTD
PMID:21641980
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
G
Hivep1
HIVEP zinc finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIVEP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIVEP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
G
Hivep3
HIVEP zinc finger 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HIVEP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HIVEP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
G
Hk3
hexokinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HK3 mRNA
CTD
PMID:21641980
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
G
Hmgb2
high mobility group box 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGB2 mRNA
CTD
PMID:21641980
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGCS1 mRNA
CTD
PMID:21641980
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmmr
hyaluronan-mediated motility receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMMR mRNA
CTD
PMID:21641980
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMOX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HMOX1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmx2
H6 family homeobox 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMX2 mRNA
CTD
PMID:21641980
NCBI chr 1:186,319,110...186,326,771
Ensembl chr 1:186,319,110...186,326,771
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:21641980
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA3 mRNA
CTD
PMID:21641980
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPDL mRNA
CTD
PMID:21641980
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnph1
heterogeneous nuclear ribonucleoprotein H1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HNRNPH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
G
Hnrnph3
heterogeneous nuclear ribonucleoprotein H3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH3 mRNA
CTD
PMID:21641980
NCBI chr20:25,616,400...25,625,814
Ensembl chr20:25,614,733...25,625,750
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HPD mRNA
CTD
PMID:26378955
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
G
Hpgds
hematopoietic prostaglandin D synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HPGDS mRNA
CTD
PMID:21641980
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
G
Hsp90b1
heat shock protein 90 beta family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSP90B1 mRNA
CTD
PMID:21641980
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA1B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HSPA1B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa4
heat shock protein family A (Hsp70) member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA4 mRNA
CTD
PMID:21641980
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hunk
hormonally upregulated Neu-associated kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of HUNK mRNA
CTD
PMID:21641980
NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526
G
Hycc1
hyccin PI4KA lipid kinase complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC1 mRNA
CTD
PMID:21641980
NCBI chr 4:11,132,224...11,239,120
Ensembl chr 4:11,132,385...11,239,113
G
Hycc2
hyccin PI4KA lipid kinase complex subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC2 mRNA
CTD
PMID:21641980
NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ICAM1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ICAM1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID1 mRNA [Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID1 mRNA
CTD
PMID:25522732
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID2 mRNA
CTD
PMID:25522732
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID3 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ID3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ID3 mRNA
CTD
PMID:21641980 PMID:25522732 PMID:26378955
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Id4
inhibitor of DNA binding 4
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID4 mRNA
CTD
PMID:25522732
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Ide
insulin degrading enzyme
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDE mRNA
CTD
PMID:26378955
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
G
Idi1
isopentenyl-diphosphate delta isomerase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IDI1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDI1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ier3
immediate early response 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IER3 mRNA
CTD
PMID:21641980
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi27
interferon, alpha-inducible protein 27
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI27 mRNA
CTD
PMID:26378955
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI27L2A mRNA
CTD
PMID:21641980
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
G
Ifi35
interferon-induced protein 35
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA
CTD
PMID:21641980
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44 mRNA
CTD
PMID:21641980
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44L mRNA
CTD
PMID:21641980
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFIH1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit1
interferon-induced protein with tetratricopeptide repeats 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT1 mRNA
CTD
PMID:21641980
NCBI chr 1:232,152,038...232,154,103
Ensembl chr 1:232,127,170...232,154,435
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT3 mRNA
CTD
PMID:21641980
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifnar2
interferon alpha and beta receptor subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFNAR2 mRNA
CTD
PMID:21641980
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
G
Ift57
intraflagellar transport 57
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IFT57 mRNA
CTD
PMID:26378955
NCBI chr11:51,051,520...51,124,909
Ensembl chr11:51,059,611...51,124,812
G
Ift74
intraflagellar transport 74
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT74 mRNA
CTD
PMID:21641980
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
G
Ift80
intraflagellar transport 80
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT80 mRNA
CTD
PMID:21641980
NCBI chr 2:153,144,707...153,240,024
Ensembl chr 2:153,145,795...153,240,024
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1R mRNA
CTD
PMID:26378955
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF2BP1 mRNA
CTD
PMID:26378955
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGF2BP2 mRNA
CTD
PMID:21641980
NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA
CTD
PMID:26378955
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp3
insulin-like growth factor binding protein 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP3 mRNA
CTD
PMID:26378955
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp4
insulin-like growth factor binding protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGFBP4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
G
Igfbp5
insulin-like growth factor binding protein 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP5 mRNA
CTD
PMID:26378955
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igfbp6
insulin-like growth factor binding protein 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP6 mRNA
CTD
PMID:26378955
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
G
Igsf3
immunoglobulin superfamily, member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGSF3 mRNA
CTD
PMID:21641980
NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645
G
Igsf6
immunoglobulin superfamily, member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGSF6 mRNA
CTD
PMID:21641980
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
G
Ihh
Indian hedgehog signaling molecule
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IHH mRNA
CTD
PMID:26378955
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKE mRNA
CTD
PMID:21641980
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKG mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKBKG mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Ikzf1
IKAROS family zinc finger 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKZF1 mRNA
CTD
PMID:26378955
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Ikzf5
IKAROS family zinc finger 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IKZF5 mRNA
CTD
PMID:26378955
NCBI chr 1:186,169,108...186,188,847
Ensembl chr 1:186,170,788...186,188,834
G
Il13ra1
interleukin 13 receptor subunit alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL13RA1 mRNA
CTD
PMID:21641980
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il13ra2
interleukin 13 receptor subunit alpha 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL13RA2 mRNA
CTD
PMID:21641980
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il18rap
interleukin 18 receptor accessory protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL18RAP mRNA
CTD
PMID:21641980
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1B mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IL1B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RL1 mRNA
CTD
PMID:21641980
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RN mRNA
CTD
PMID:21641980
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il4i1
interleukin 4 induced 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL4I1 mRNA
CTD
PMID:21641980
NCBI chr 1:95,299,457...95,324,564
Ensembl chr 1:95,295,601...95,324,562
G
Il6
interleukin 6
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein]
CTD
PMID:31163222
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6RA mRNA
CTD
PMID:21641980
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6ST mRNA
CTD
PMID:21641980
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Inpp5d
inositol polyphosphate-5-phosphatase D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INPP5D mRNA
CTD
PMID:21641980
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Insig1
insulin induced gene 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INSIG1 mRNA
CTD
PMID:21641980
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRAK2 mRNA
CTD
PMID:21641980
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Irf4
interferon regulatory factor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF4 mRNA
CTD
PMID:21641980
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf7
interferon regulatory factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF7 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IRF7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irf9
interferon regulatory factor 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF9 mRNA
CTD
PMID:21641980
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Irgm
immunity-related GTPase M
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRGM1 mRNA
CTD
PMID:21641980
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG15 mRNA
CTD
PMID:21641980
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ISG20 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itga4
integrin subunit alpha 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGA4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itgam
integrin subunit alpha M
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAM mRNA
CTD
PMID:26378955
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgav
integrin subunit alpha V
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAV mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAV mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Itgax
integrin subunit alpha X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAX mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb5
integrin subunit beta 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGB5 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGB5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Itgb7
integrin subunit beta 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGB7 mRNA
CTD
PMID:21641980
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITPR1 mRNA
CTD
PMID:26378955
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITPR2 mRNA
CTD
PMID:26378955
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Itsn2
intersectin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITSN2 mRNA
CTD
PMID:26378955
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
G
Jade1
jade family PHD finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JADE1 mRNA
CTD
PMID:21641980
NCBI chr 2:124,543,233...124,596,361
Ensembl chr 2:124,543,286...124,596,354
G
Jade2
jade family PHD finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JADE2 mRNA
CTD
PMID:21641980
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
G
Jag1
jagged canonical Notch ligand 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JAG1 mRNA
CTD
PMID:26378955
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jak2
Janus kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JAK2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAK2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jazf1
JAZF zinc finger 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAZF1 mRNA
CTD
PMID:26378955
NCBI chr 4:81,879,501...82,183,237
Ensembl chr 4:81,881,061...82,183,100
G
Jdp2
Jun dimerization protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of JDP2 mRNA
CTD
PMID:21641980
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jmjd1c
jumonji domain containing 1C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JMJD1C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JMJD1C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Kank2
KN motif and ankyrin repeat domains 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KANK2 mRNA
CTD
PMID:21641980
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
G
Kat14
lysine acetyltransferase 14
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KAT14 mRNA
CTD
PMID:26378955
NCBI chr 3:131,736,430...131,781,732
Ensembl chr 3:131,736,549...131,781,706
G
Kat7
lysine acetyltransferase 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KAT7 mRNA
CTD
PMID:21641980
NCBI chr10:80,221,519...80,255,590
Ensembl chr10:80,221,524...80,255,567
G
Kbtbd11
kelch repeat and BTB domain containing 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD11 mRNA
CTD
PMID:21641980
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kbtbd7
kelch repeat and BTB domain containing 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD7 mRNA
CTD
PMID:21641980
NCBI chr15:54,806,878...54,811,457
Ensembl chr15:54,806,873...54,811,687
G
Kctd12
potassium channel tetramerization domain containing 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of KCTD12 mRNA
CTD
PMID:21641980
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
G
Kdm4c
lysine demethylase 4C
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KDM4C mRNA
CTD
PMID:26378955
NCBI chr 5:88,100,710...88,306,821
Ensembl chr 5:88,100,733...88,306,818
G
Kdm5a
lysine demethylase 5A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KDM5A mRNA
CTD
PMID:26378955
NCBI chr 4:153,565,909...153,643,912
Ensembl chr 4:153,565,846...153,642,422
G
Kdm7a
lysine demethylase 7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KDM7A mRNA
CTD
PMID:21641980
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
G
Kif11
kinesin family member 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF11 mRNA
CTD
PMID:21641980
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Kif20b
kinesin family member 20B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF20B mRNA
CTD
PMID:21641980
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kif21b
kinesin family member 21B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF21B mRNA
CTD
PMID:21641980
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
G
Kif3c
kinesin family member 3C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of KIF3C mRNA
CTD
PMID:21641980
NCBI chr 6:26,367,092...26,406,033
Ensembl chr 6:26,366,531...26,406,130
G
Kif5b
kinesin family member 5B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF5B mRNA
CTD
PMID:21641980
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
G
Kifc3
kinesin family member C3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIFC3 mRNA
CTD
PMID:21641980
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
G
Kit
KIT proto-oncogene receptor tyrosine kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KIT mRNA
CTD
PMID:26378955
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Klf4
KLF transcription factor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KLF4 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KLF4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klf6
KLF transcription factor 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF6 mRNA
CTD
PMID:26378955
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klf7
KLF transcription factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Kmt2e
lysine methyltransferase 2E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KMT2E mRNA
CTD
PMID:21641980
NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373
G
Krr1
KRR1, small subunit processome component homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KRR1 mRNA
CTD
PMID:21641980
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
G
Layn
layilin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LAYN mRNA
CTD
PMID:21641980
NCBI chr 8:51,363,928...51,384,748
Ensembl chr 8:51,367,091...51,384,330
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCK mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:141,888,318...141,916,945
Ensembl chr 5:141,888,326...141,903,794
G
Lcn2
lipocalin 2
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in increased expression of LCN2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCN2 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:25522732 PMID:26378955
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldlrad3
low density lipoprotein receptor class A domain containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA
CTD
PMID:26378955
NCBI chr 3:88,239,529...88,481,340
Ensembl chr 3:88,239,622...88,481,267
G
Lemd3
LEM domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LEMD3 mRNA
CTD
PMID:21641980
NCBI chr 7:56,415,053...56,499,047
Ensembl chr 7:56,305,448...56,502,474
G
Lfng
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LFNG mRNA
CTD
PMID:26378955
NCBI chr12:14,030,551...14,038,996
Ensembl chr12:14,018,333...14,039,008
G
Lgals9
galectin 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LGALS9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LGALS9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in decreased expression of LHB protein]
CTD
PMID:31163222
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhx2
LIM homeobox 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LHX2 mRNA
CTD
PMID:26378955
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIF mRNA
CTD
PMID:21641980
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lig4
DNA ligase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIG4 mRNA
CTD
PMID:26378955
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
G
Lims1
LIM zinc finger domain containing 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LIMS1 mRNA
CTD
PMID:26378955
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lims2
LIM zinc finger domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIMS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:23,553,937...23,592,137
Ensembl chr18:23,553,937...23,592,137
G
Lmcd1
LIM and cysteine-rich domains 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMCD1 mRNA
CTD
PMID:26378955
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
G
Lmln
leishmanolysin like peptidase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMLN mRNA
CTD
PMID:26378955
NCBI chr11:67,656,241...67,725,889
Ensembl chr11:67,658,152...67,724,243
G
Lnpep
leucyl and cystinyl aminopeptidase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LNPEP mRNA
CTD
PMID:26378955
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
Lpar1
lysophosphatidic acid receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LPAR1 mRNA
CTD
PMID:21641980
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Lrp1
LDL receptor related protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LRP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRRC8C mRNA
CTD
PMID:21641980
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
G
Lsm1
LSM1 homolog, mRNA degradation associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM1 mRNA
CTD
PMID:21641980
NCBI chr16:66,277,345...66,288,852
Ensembl chr16:66,277,345...66,288,852
G
Lsm8
LSM8 homolog, U6 small nuclear RNA associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM8 mRNA
CTD
PMID:21641980
NCBI chr 4:47,306,259...47,312,125
Ensembl chr 4:47,306,295...47,314,293
G
Lsp1
lymphocyte-specific protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSP1 mRNA
CTD
PMID:21641980
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
G
Lss
lanosterol synthase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSS mRNA
CTD
PMID:21641980
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Ltb
lymphotoxin beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LTB mRNA
CTD
PMID:21641980
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Luc7l2
LUC7-like 2 pre-mRNA splicing factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L2 mRNA
CTD
PMID:21641980
NCBI chr 4:67,287,593...67,347,986
Ensembl chr 4:67,287,640...67,347,964
G
Luc7l3
LUC7-like 3 pre-mRNA splicing factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L3 mRNA
CTD
PMID:21641980
NCBI chr10:79,240,050...79,276,555
Ensembl chr10:79,240,563...79,276,538
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA
CTD
PMID:26378955
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Mafb
MAF bZIP transcription factor B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAFB mRNA
CTD
PMID:21641980
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Magi2
membrane associated guanylate kinase, WW and PDZ domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MAGI2 mRNA
CTD
PMID:21641980
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
G
Malt1
MALT1 paracaspase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MALT1 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MALT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MALT1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:58,942,282...58,996,318
Ensembl chr18:58,942,299...58,994,260
G
Map3k2
mitogen activated protein kinase kinase kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MAP3K2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K2 mRNA
CTD
PMID:26378955
NCBI chr18:23,807,218...23,879,722
Ensembl chr18:23,807,218...23,871,433
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mapk1ip1l
mitogen-activated protein kinase 1 interacting protein 1-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK1IP1L mRNA
CTD
PMID:21641980
NCBI chr15:20,545,043...20,571,466
Ensembl chr15:20,545,059...20,569,674
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAPK8 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapre2
microtubule-associated protein, RP/EB family, member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPRE2 mRNA
CTD
PMID:21641980
NCBI chr18:15,028,675...15,169,553
Ensembl chr18:15,029,041...15,168,044
G
Marcks
myristoylated alanine rich protein kinase C substrate
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKS mRNA
CTD
PMID:21641980
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Marcksl1
MARCKS-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKSL1 mRNA
CTD
PMID:21641980
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Marveld1
MARVEL domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MARVELD1 mRNA
CTD
PMID:21641980
NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384
G
Matr3
matrin 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MATR3 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MATR3 mRNA
CTD
PMID:26378955
NCBI chr18:27,154,098...27,193,212
Ensembl chr18:27,163,714...27,193,166
G
Mbnl2
muscleblind-like splicing regulator 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MBNL2 mRNA
CTD
PMID:26378955
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mbnl3
muscleblind-like splicing regulator 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MBNL3 mRNA
CTD
PMID:26378955
NCBI chr X:130,641,942...130,737,179
Ensembl chr X:130,648,538...130,737,056
G
Mbtd1
mbt domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MBTD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MBTD1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:78,839,140...78,895,413
Ensembl chr10:78,839,036...78,893,720
G
Mchr1
melanin-concentrating hormone receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCHR1 mRNA
CTD
PMID:21641980
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
G
Mcoln2
mucolipin TRP cation channel 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCOLN2 mRNA
CTD
PMID:21641980
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
G
Mdm2
MDM2 proto-oncogene
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MDM2 mRNA
CTD
PMID:26378955
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mecom
MDS1 and EVI1 complex locus
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MECOM mRNA
CTD
PMID:26378955
NCBI chr 2:112,909,353...113,464,583
Ensembl chr 2:112,909,321...113,464,590
G
Mecp2
methyl CpG binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MECP2 mRNA
CTD
PMID:21641980
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Med13
mediator complex subunit 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MED13 mRNA
CTD
PMID:21641980
NCBI chr10:71,086,978...71,176,535
Ensembl chr10:71,090,516...71,177,242
G
Mef2a
myocyte enhancer factor 2a
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2A mRNA
CTD
PMID:21641980
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
G
Mef2c
myocyte enhancer factor 2C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2C mRNA
CTD
PMID:21641980
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
G
Mesp2
mesoderm posterior bHLH transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MESP2 mRNA
CTD
PMID:21641980
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
G
Mfap3l
microfibril associated protein 3 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFAP3L mRNA
CTD
PMID:21641980
NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863
G
Mfsd11
major facilitator superfamily domain containing 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MFSD11 mRNA
CTD
PMID:21641980
NCBI chr10:102,055,516...102,075,064
Ensembl chr10:102,056,051...102,075,064
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFSD2 mRNA
CTD
PMID:21641980
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mga
MAX dimerization protein MGA
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MGA mRNA
CTD
PMID:21641980
NCBI chr 3:106,851,216...106,942,908
Ensembl chr 3:106,851,140...106,941,043
G
Mgat4a
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT4A mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MGAT4A mRNA
CTD
PMID:26378955
NCBI chr 9:39,673,427...39,786,747
Ensembl chr 9:39,673,430...39,766,890
G
Mgat5b
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA
CTD
PMID:26378955
NCBI chr10:102,120,757...102,190,235
Ensembl chr10:102,120,445...102,190,233
G
Mgst2
microsomal glutathione S-transferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MGST2 mRNA
CTD
PMID:21641980
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mia3
MIA SH3 domain ER export factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIA3 mRNA
CTD
PMID:21641980
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
G
Mical2
microtubule associated monooxygenase, calponin and LIM domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MICAL2 mRNA
CTD
PMID:26378955
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
G
Micall2
MICAL-like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MICALL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MICALL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:14,899,188...14,927,949
Ensembl chr12:14,899,157...14,927,946
G
Mid1
midline 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MID1 mRNA
CTD
PMID:26378955
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
G
Mindy2
MINDY lysine 48 deubiquitinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MINDY2 mRNA
CTD
PMID:21641980
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
G
Mix23
mitochondrial matrix import factor 23
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIX23 mRNA
CTD
PMID:21641980
NCBI chr11:64,660,711...64,681,000
Ensembl chr11:64,660,711...64,681,000
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA
CTD
PMID:21641980
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MLLT10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MLLT10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:80,821,870...80,949,349
Ensembl chr17:80,822,556...80,949,345
G
Mmp10
matrix metallopeptidase 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP10 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp11
matrix metallopeptidase 11
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP11 mRNA
CTD
PMID:26378955
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
G
Mmp12
matrix metallopeptidase 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP12 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mnda
myeloid cell nuclear differentiation antigen
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA
CTD
PMID:21641980
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mocos
molybdenum cofactor sulfurase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOCOS mRNA
CTD
PMID:21641980
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
G
Mospd2
motile sperm domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MOSPD2 mRNA
CTD
PMID:21641980
NCBI chr X:29,420,485...29,472,099
Ensembl chr X:29,420,586...29,462,398
G
Mov10
Mov10 RNA helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOV10 mRNA
CTD
PMID:21641980
NCBI chr 2:192,292,041...192,315,142
Ensembl chr 2:192,293,470...192,315,083
G
Mrpl50
mitochondrial ribosomal protein L50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPL50 mRNA
CTD
PMID:21641980
NCBI chr 5:63,867,437...63,872,591
G
Mrps6
mitochondrial ribosomal protein S6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPS6 mRNA
CTD
PMID:21641980
NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484
G
Msgn1
mesogenin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSGN1 mRNA
CTD
PMID:21641980
NCBI chr 6:33,912,787...33,913,427
Ensembl chr 6:33,912,787...33,913,427
G
Msh2
mutS homolog 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MSH2 mRNA
CTD
PMID:21641980
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Msh5
mutS homolog 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSH5 mRNA
CTD
PMID:21641980
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
G
Mt1
metallothionein 1
multiple interactions
EXP ISO
Succimer inhibits the reaction [sodium arsenite results in increased secretion of MT1 protein] [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT1 mRNA
CTD
PMID:21641980 PMID:26378955 PMID:31163222
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT2A mRNA
CTD
PMID:26378955
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtf1
metal-regulatory transcription factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MTF1 mRNA
CTD
PMID:26378955
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
G
Mtf2
metal response element binding transcription factor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MTF2 mRNA
CTD
PMID:26378955
NCBI chr14:1,639,256...1,683,513
Ensembl chr14:1,640,746...1,683,524
G
Mtrex
Mtr4 exosome RNA helicase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTREX mRNA
CTD
PMID:21641980
NCBI chr 2:44,500,326...44,560,624
Ensembl chr 2:44,461,444...44,560,627
G
Mtss1
MTSS I-BAR domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTSS1 mRNA
CTD
PMID:21641980
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Mtx3
metaxin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTX3 mRNA
CTD
PMID:21641980
NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670
G
Muc20
mucin 20, cell surface associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUC20 mRNA
CTD
PMID:21641980
NCBI chr11:67,987,816...68,001,496
Ensembl chr11:67,987,800...68,001,495
G
Mustn1
musculoskeletal, embryonic nuclear protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUSTN1 mRNA
CTD
PMID:21641980
NCBI chr16:6,072,908...6,075,161
Ensembl chr16:6,072,833...6,075,161
G
Mvd
mevalonate diphosphate decarboxylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MVD mRNA
CTD
PMID:21641980
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mxd4
Max dimerization protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MXD4 mRNA
CTD
PMID:21641980
NCBI chr14:76,562,105...76,576,224
Ensembl chr14:76,561,774...76,576,221
G
Myb
MYB proto-oncogene, transcription factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYB mRNA
CTD
PMID:26378955
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYC mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MYC mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myh14
myosin heavy chain 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYH14 mRNA
CTD
PMID:21641980
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
G
Mylk
myosin light chain kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYLK mRNA
CTD
PMID:26378955
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
N4bp2
NEDD4 binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2 mRNA
CTD
PMID:21641980
NCBI chr14:42,342,690...42,479,861
Ensembl chr14:42,409,510...42,483,960
G
N4bp2l1
NEDD4 binding protein 2-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2L1 mRNA
CTD
PMID:21641980
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
Naa50
N(alpha)-acetyltransferase 50, NatE catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAA50 mRNA
CTD
PMID:21641980
NCBI chr11:56,538,366...56,560,842
Ensembl chr11:56,538,366...56,560,842
G
Nabp1
nucleic acid binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NABP1 mRNA
CTD
PMID:21641980
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Naip6
NLR family, apoptosis inhibitory protein 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NAIP mRNA
CTD
PMID:26378955
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
G
Nav1
neuron navigator 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA
CTD
PMID:21641980
NCBI chr13:46,866,972...47,119,368
Ensembl chr13:46,873,689...47,126,449
G
Nav2
neuron navigator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV2 mRNA
CTD
PMID:21641980
NCBI chr 1:98,957,629...99,322,339
Ensembl chr 1:98,663,759...99,322,337
G
Nbeal1
neurobeachin-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NBEAL1 mRNA
CTD
PMID:21641980
NCBI chr 9:61,575,154...61,743,896
Ensembl chr 9:61,575,356...61,736,750
G
Ncapg2
non-SMC condensin II complex, subunit G2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCAPG2 mRNA
CTD
PMID:21641980
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NCF1 mRNA
CTD
PMID:26378955
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nckap1
NCK-associated protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NCKAP1 mRNA
CTD
PMID:21641980
NCBI chr 3:65,417,450...65,491,769
Ensembl chr 3:65,417,453...65,492,217
G
Ncl
nucleolin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCL mRNA
CTD
PMID:21641980
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCOA2 mRNA
CTD
PMID:21641980
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Ndc1
NDC1 transmembrane nucleoporin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDC1 mRNA
CTD
PMID:21641980
NCBI chr 5:122,155,992...122,202,295
Ensembl chr 5:122,155,967...122,202,291
G
Ndrg1
N-myc downstream regulated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG1 mRNA
CTD
PMID:21641980
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg2
NDRG family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG2 mRNA
CTD
PMID:21641980
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Ndufa10
NADH:ubiquinone oxidoreductase subunit A10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFA10 mRNA
CTD
PMID:21641980
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFAB1 mRNA
CTD
PMID:21641980
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
G
Nectin2
nectin cell adhesion molecule 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NECTIN2 mRNA
CTD
PMID:21641980
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Nectin3
nectin cell adhesion molecule 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NECTIN3 mRNA
CTD
PMID:21641980
NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519
G
Nek2
NIMA-related kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK2 mRNA
CTD
PMID:26378955
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
G
Nek3
NIMA-related kinase 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK3 mRNA
CTD
PMID:26378955
NCBI chr16:69,867,020...69,892,477
Ensembl chr16:69,867,047...69,892,508
G
Nemf
nuclear export mediator factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NEMF mRNA
CTD
PMID:21641980
NCBI chr 6:87,791,650...87,835,826
Ensembl chr 6:87,791,656...87,835,841
G
Nfat5
nuclear factor of activated T-cells 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFAT5 mRNA
CTD
PMID:21641980
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nfatc3
nuclear factor of activated T-cells 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFATC3 mRNA
CTD
PMID:21641980
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfix
nuclear factor I X
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFIX mRNA
CTD
PMID:21641980
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFKB1 mRNA Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of NFKB1 mRNA]
CTD
PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB2 mRNA
CTD
PMID:21641980
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIA mRNA
CTD
PMID:21641980
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIE mRNA
CTD
PMID:21641980
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfkbiz
NFKB inhibitor zeta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIZ mRNA
CTD
PMID:21641980
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nfx1
nuclear transcription factor, X-box binding 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFX1 mRNA
CTD
PMID:26378955
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
G
Ninj1
ninjurin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NINJ1 mRNA
CTD
PMID:21641980
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NKD1 mRNA
CTD
PMID:26378955
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
G
Nktr
natural killer cell triggering receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NKTR mRNA
CTD
PMID:21641980
NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314
G
Nlk
nemo like kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NLK mRNA
CTD
PMID:26378955
NCBI chr10:63,467,388...63,590,960
Ensembl chr10:63,438,222...63,589,730
G
Nln
neurolysin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLN mRNA
CTD
PMID:26378955
NCBI chr 2:35,133,634...35,232,927
Ensembl chr 2:35,134,145...35,232,914
G
Nlrc4
NLR family, CARD domain containing 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRC4 mRNA
CTD
PMID:26378955
NCBI chr 6:20,991,785...21,018,254
Ensembl chr 6:20,995,266...21,018,248
G
Nlrp10
NLR family, pyrin domain containing 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NLRP10 mRNA
CTD
PMID:21641980
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NLRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nnmt
nicotinamide N-methyltransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NNMT mRNA
CTD
PMID:26378955
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
G
Npas2
neuronal PAS domain protein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPAS2 mRNA
CTD
PMID:26378955
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Nptx1
neuronal pentraxin 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NPTX1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPTX1 mRNA
CTD
PMID:26378955
NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
G
Npy
neuropeptide Y
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of NPY mRNA
CTD
PMID:21641980
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NQO1 mRNA
CTD
PMID:26378955
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR1D2 mRNA
CTD
PMID:26378955
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Nr2c2
nuclear receptor subfamily 2, group C, member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR2C2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of NR2C2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR2F2 mRNA
CTD
PMID:26378955
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR3C1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR3C1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NR5A2 mRNA
CTD
PMID:26378955
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nrip1
nuclear receptor interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRIP1 mRNA
CTD
PMID:21641980
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Nrp1
neuropilin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NRP1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrp2
neuropilin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA
CTD
PMID:26378955
NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958
G
Nrxn3
neurexin 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRXN3 mRNA
CTD
PMID:26378955
NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:107,641,780...109,272,044
G
Nsd1
nuclear receptor binding SET domain protein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NSD1 mRNA
CTD
PMID:26378955
NCBI chr17:9,311,963...9,426,373
Ensembl chr17:9,315,237...9,425,358
G
Nuak2
NUAK family kinase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUAK2 mRNA
CTD
PMID:26378955
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
G
Nudt11
nudix hydrolase 11
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUDT11 mRNA
CTD
PMID:26378955
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Nudt5
nudix hydrolase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUDT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NUDT5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:72,435,690...72,459,008
Ensembl chr17:72,435,697...72,459,001
G
Nupr1
nuclear protein 1, transcriptional regulator
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUPR1 mRNA
CTD
PMID:21641980
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Oas1a
2'-5' oligoadenylate synthetase 1A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS1 mRNA
CTD
PMID:26378955
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oas2
2'-5' oligoadenylate synthetase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:35,802,824...35,830,778
Ensembl chr12:35,806,759...35,829,371
G
Oas3
2'-5'-oligoadenylate synthetase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Oasl
2'-5'-oligoadenylate synthetase-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OASL1 mRNA
CTD
PMID:21641980
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Ocstamp
osteoclast stimulatory transmembrane protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OCSTAMP mRNA
CTD
PMID:21641980
NCBI chr 3:154,131,113...154,141,611
Ensembl chr 3:154,132,328...154,136,991
G
Odc1
ornithine decarboxylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ODC1 mRNA
CTD
PMID:21641980
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ogfrl1
opioid growth factor receptor-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of OGFRL1 mRNA
CTD
PMID:21641980
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
G
Oit3
oncoprotein induced transcript 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OIT3 mRNA
CTD
PMID:21641980
NCBI chr20:27,390,113...27,410,692
Ensembl chr20:27,390,113...27,410,692
G
Orc3
origin recognition complex, subunit 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ORC3 mRNA
CTD
PMID:21641980
NCBI chr 5:49,123,758...49,181,552
Ensembl chr 5:49,126,955...49,181,633
G
Osgin2
oxidative stress induced growth inhibitor family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OSGIN2 mRNA
CTD
PMID:21641980
NCBI chr 5:29,500,406...29,519,340
Ensembl chr 5:29,500,408...29,520,831
G
Otud4
OTU deubiquitinase 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of OTUD4 mRNA
CTD
PMID:26378955
NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815
G
Ovol2
ovo-like zinc finger 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OVOL2 mRNA
CTD
PMID:26378955
NCBI chr 3:131,677,391...131,707,123
Ensembl chr 3:131,677,391...131,708,359
G
Pacrg
parkin coregulated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PACRG mRNA
CTD
PMID:21641980
NCBI chr 1:49,882,671...50,305,564
Ensembl chr 1:49,882,630...50,305,430
G
Padi2
peptidyl arginine deiminase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PADI2 mRNA
CTD
PMID:21641980
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:21641980
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
G
Pald1
phosphatase domain containing, paladin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALD1 mRNA
CTD
PMID:21641980
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
G
Pals2
protein associated with LIN7 2, MAGUK p55 family member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALS2 mRNA
CTD
PMID:21641980
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
G
Pank1
pantothenate kinase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PANK1 mRNA
CTD
PMID:21641980
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Pappa
pappalysin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PAPPA mRNA
CTD
PMID:26378955
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
Succimer inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein]
CTD
PMID:31163222
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp12
poly (ADP-ribose) polymerase family, member 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PARP12 mRNA
CTD
PMID:26378955
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Parp3
poly (ADP-ribose) polymerase family, member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PARP3 mRNA
CTD
PMID:21641980
NCBI chr 8:107,111,010...107,117,073
Ensembl chr 8:107,111,012...107,116,782
G
Patz1
POZ (BTB) and AT hook containing zinc finger 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PATZ1 mRNA
CTD
PMID:26378955
NCBI chr14:78,154,590...78,173,032
Ensembl chr14:78,152,516...78,173,032
G
Pcbp2
poly(rC) binding protein 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCBP2 mRNA
CTD
PMID:26378955
NCBI chr 7:133,605,375...133,631,312
Ensembl chr 7:133,605,573...133,629,863
G
Pcgf2
polycomb group ring finger 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF2 mRNA
CTD
PMID:26378955
NCBI chr10:82,682,563...82,694,563
Ensembl chr10:82,683,553...82,693,406
G
Pcgf5
polycomb group ring finger 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF5 mRNA
CTD
PMID:26378955
NCBI chr 1:234,063,854...234,180,022
Ensembl chr 1:234,063,892...234,175,315
G
Pcm1
pericentriolar material 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCM1 mRNA
CTD
PMID:21641980
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
G
Pcmtd1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCMTD1 mRNA
CTD
PMID:21641980
NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
G
Pdcd1
programmed cell death 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDCD1 mRNA
CTD
PMID:21641980
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdcd4
programmed cell death 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD4 mRNA
CTD
PMID:21641980
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd6
programmed cell death 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDCD6 mRNA
CTD
PMID:26378955
NCBI chr 1:28,966,518...28,982,188
Ensembl chr 1:28,966,518...28,982,189
G
Pdcd6ip
programmed cell death 6 interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD6IP mRNA
CTD
PMID:21641980
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
G
Pde1a
phosphodiesterase 1A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE1A mRNA
CTD
PMID:26378955
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde4b
phosphodiesterase 4B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDE4B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE4B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pde4dip
phosphodiesterase 4D interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDE4DIP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDE4DIP mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pde7a
phosphodiesterase 7A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE7A mRNA
CTD
PMID:26378955
NCBI chr 2:101,714,767...101,806,853
Ensembl chr 2:101,718,444...101,806,681
G
Pde8b
phosphodiesterase 8B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE8B mRNA
CTD
PMID:26378955
NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209
G
Pdlim5
PDZ and LIM domain 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM5 mRNA
CTD
PMID:26378955
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
G
Pdlim7
PDZ and LIM domain 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM7 mRNA
CTD
PMID:26378955
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
G
Pdpn
podoplanin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDPN mRNA
CTD
PMID:21641980
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Pdss1
decaprenyl diphosphate synthase subunit 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDSS1 mRNA
CTD
PMID:26378955
NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730
G
Pf4
platelet factor 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PF4 mRNA
CTD
PMID:26378955
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PGGT1B mRNA
CTD
PMID:26378955
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
G
Pgm2l1
phosphoglucomutase 2-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PGM2L1 mRNA
CTD
PMID:21641980
NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:154,571,766...154,620,902
G
Pgm5
phosphoglucomutase 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PGM5 mRNA
CTD
PMID:21641980
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Phb2
prohibitin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHB2 mRNA
CTD
PMID:21641980
NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272
G
Phc3
polyhomeotic homolog 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHC3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHC3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:112,408,709...112,483,719
Ensembl chr 2:112,408,531...112,476,540
G
Phf20l1
PHD finger protein 20-like 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF20L1 mRNA
CTD
PMID:26378955
NCBI chr 7:98,330,580...98,396,526
Ensembl chr 7:98,330,580...98,396,526
G
Phf3
PHD finger protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:33,063,855...33,136,013
Ensembl chr 9:33,063,857...33,135,994
G
Phf6
PHD finger protein 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHF6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
G
Phip
pleckstrin homology domain interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHIP mRNA
CTD
PMID:21641980
NCBI chr 8:83,776,802...83,891,192
Ensembl chr 8:83,781,465...83,894,283
G
Phlda1
pleckstrin homology-like domain, family A, member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PHLDA1 mRNA
CTD
PMID:21641980
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pias2
protein inhibitor of activated STAT, 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PIAS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr18:70,608,034...70,714,295
Ensembl chr18:70,607,665...70,710,033
G
Piezo2
piezo-type mechanosensitive ion channel component 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIEZO2 mRNA
CTD
PMID:21641980
NCBI chr18:56,468,449...56,844,984
Ensembl chr18:56,469,680...56,844,216
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3CA mRNA
CTD
PMID:21641980
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:21641980
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pilra
paired immunoglobin-like type 2 receptor alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PILRA mRNA
CTD
PMID:21641980
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIM1 mRNA
CTD
PMID:21641980
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Pink1
PTEN induced kinase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PINK1 mRNA
CTD
PMID:26378955
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pip4k2a
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIP4K2A mRNA
CTD
PMID:21641980
NCBI chr17:81,496,669...81,668,180
Ensembl chr17:81,496,670...81,668,029
G
Pip5k1b
phosphatidylinositol-4-phosphate 5-kinase type 1 beta
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIP5K1B mRNA
CTD
PMID:21641980
NCBI chr 1:221,907,220...222,183,672
Ensembl chr 1:221,914,159...222,183,672
G
Pir
pirin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PIR mRNA
CTD
PMID:26378955
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pira2
paired-Ig-like receptor A2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIRA2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIRA2 mRNA
CTD
PMID:21641980
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pitpnm1
phosphatidylinositol transfer protein, membrane-associated 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PITPNM1 mRNA
CTD
PMID:26378955
NCBI chr 1:201,394,099...201,407,523
Ensembl chr 1:201,394,149...201,407,522
G
Pja2
praja ring finger ubiquitin ligase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PJA2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PJA2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:103,956,678...104,006,763
Ensembl chr 9:103,956,678...104,006,783
G
Pkd2
polycystin 2, transient receptor potential cation channel
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PKD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Pklr
pyruvate kinase L/R
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKLR mRNA
CTD
PMID:26378955
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Plagl2
PLAG1 like zinc finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAGL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAGL2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:141,695,322...141,708,516
Ensembl chr 3:141,695,322...141,708,503
G
Plau
plasminogen activator, urokinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAU mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAU mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAUR mRNA
CTD
PMID:21641980
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plcb4
phospholipase C, beta 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLCB4 mRNA
CTD
PMID:21641980
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
G
Pld3
phospholipase D family, member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLD3 mRNA
CTD
PMID:21641980
NCBI chr 1:82,821,863...82,844,280
Ensembl chr 1:82,821,875...82,844,072
G
Plk2
polo-like kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLK2 mRNA
CTD
PMID:21641980
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plk4
polo-like kinase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLK4 mRNA
CTD
PMID:21641980
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
G
Plpp3
phospholipid phosphatase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLPP3 mRNA
CTD
PMID:21641980
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Plxdc1
plexin domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLXDC1 mRNA
CTD
PMID:21641980
NCBI chr10:82,922,499...82,982,124
Ensembl chr10:82,922,508...82,982,130
G
Pmepa1
prostate transmembrane protein, androgen induced 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMEPA1 mRNA
CTD
PMID:21641980
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pms1
PMS1 homolog 1, mismatch repair system component
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMS1 mRNA
CTD
PMID:21641980
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pnisr
PNN interacting serine and arginine rich protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNISR mRNA
CTD
PMID:21641980
NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
G
Pnn
pinin, desmosome associated protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNN mRNA
CTD
PMID:21641980
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
G
Pnpla6
patatin-like phospholipase domain containing 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PNPLA6 mRNA
CTD
PMID:26378955
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Poglut3
protein O-glucosyltransferase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POGLUT3 mRNA
CTD
PMID:21641980
NCBI chr 8:53,777,614...53,795,404
Ensembl chr 8:53,777,785...53,795,399
G
Pola1
DNA polymerase alpha 1, catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POLA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Polr1a
RNA polymerase I subunit A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLR1A mRNA
CTD
PMID:26378955
NCBI chr 4:103,950,051...104,014,022
Ensembl chr 4:103,950,051...104,014,020
G
Pou2f2
POU class 2 homeobox 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of POU2F2 mRNA
CTD
PMID:21641980
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA
CTD
PMID:26378955
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppfia3
PTPRF interacting protein alpha 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIA3 mRNA
CTD
PMID:21641980
NCBI chr 1:95,817,110...95,845,950
Ensembl chr 1:95,817,110...95,845,798
G
Ppfibp2
PPFIA binding protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIBP2 mRNA
CTD
PMID:21641980
NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
G
Ppwd1
peptidylprolyl isomerase domain and WD repeat containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PPWD1 mRNA
CTD
PMID:21641980
NCBI chr 2:35,337,301...35,360,661
Ensembl chr 2:35,335,962...35,360,460
G
Pram1
PML-RARA regulated adaptor molecule 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRAM1 mRNA
CTD
PMID:21641980
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
G
Prdm1
PR/SET domain 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM1 mRNA
CTD
PMID:26378955
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Prdm2
PR/SET domain 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM2 mRNA
CTD
PMID:26378955
NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825
G
Prim2
DNA primase subunit 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRIM2 mRNA
CTD
PMID:26378955
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA
CTD
PMID:26378955
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PRKAR2B mRNA
CTD
PMID:26378955
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
G
Prkcb
protein kinase C, beta
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKCB mRNA
CTD
PMID:26378955
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Procr
protein C receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PROCR mRNA
CTD
PMID:21641980
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Prpf38b
pre-mRNA processing factor 38B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF38B mRNA
CTD
PMID:21641980
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
G
Prpf39
pre-mRNA processing factor 39
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF39 mRNA
CTD
PMID:21641980
NCBI chr 6:83,088,981...83,113,826
Ensembl chr 6:83,088,986...83,113,825
G
Prpf40a
pre-mRNA processing factor 40 homolog A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF40A mRNA
CTD
PMID:21641980
NCBI chr 3:37,625,585...37,689,859
Ensembl chr 3:37,627,690...37,690,886
G
Prpf4b
pre-mRNA processing factor 4B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF4B mRNA
CTD
PMID:21641980
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
G
Prrc1
proline-rich coiled-coil 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRRC1 mRNA
CTD
PMID:21641980
NCBI chr18:50,812,548...50,846,273
Ensembl chr18:50,812,552...50,849,476
G
Prrg4
proline rich and Gla domain 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRG4 mRNA
CTD
PMID:21641980
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Prrt1
proline-rich transmembrane protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRT1 mRNA
CTD
PMID:21641980
NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600
G
Prss50
serine protease 50
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRSS50 mRNA
CTD
PMID:21641980
NCBI chr 8:110,842,525...110,848,855
Ensembl chr 8:110,842,671...110,848,802
G
Psma1
proteasome 20S subunit alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PSMA1 mRNA
CTD
PMID:21641980
NCBI chr 1:168,442,421...168,453,440
Ensembl chr 1:168,440,936...168,453,472
G
Ptch2
patched 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTCH2 mRNA
CTD
PMID:21641980
NCBI chr 5:130,571,956...130,592,506
Ensembl chr 5:130,572,312...130,592,405
G
Ptgir
prostaglandin I2 receptor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGIR mRNA
CTD
PMID:21641980
NCBI chr 1:77,579,596...77,581,979
Ensembl chr 1:77,579,596...77,581,979
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTGS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of PTGS1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN11 mRNA
CTD
PMID:26378955
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpn14
protein tyrosine phosphatase, non-receptor type 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN14 mRNA
CTD
PMID:21641980
NCBI chr13:101,268,258...101,420,508
Ensembl chr13:101,268,416...101,414,088
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPN2 mRNA
CTD
PMID:21641980
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN22 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN22 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Ptprc
protein tyrosine phosphatase, receptor type, C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPRC mRNA
CTD
PMID:21641980
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Pus3
pseudouridine synthase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PUS3 mRNA
CTD
PMID:21641980
NCBI chr 8:33,910,461...33,918,716
Ensembl chr 8:33,911,357...33,918,714
G
Pxk
PX domain containing serine/threonine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PXK mRNA
CTD
PMID:21641980
NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444
G
Pxmp4
peroxisomal membrane protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PXMP4 mRNA
CTD
PMID:21641980
NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651
G
Qpct
glutaminyl-peptide cyclotransferase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of QPCT mRNA
CTD
PMID:26378955
NCBI chr 6:15,964,656...15,996,730
Ensembl chr 6:15,964,657...15,996,711
G
Qser1
glutamine and serine rich 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of QSER1 mRNA
CTD
PMID:21641980
NCBI chr 3:91,137,516...91,202,426
Ensembl chr 3:91,140,967...91,202,052
G
Rab14
RAB14, member RAS oncogene family
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAB14 mRNA
CTD
PMID:21641980
NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172
G
Rab6a
RAB6A, member RAS oncogene family
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RAB6A mRNA
CTD
PMID:26378955
NCBI chr 1:154,957,870...155,008,922
Ensembl chr 1:154,958,189...154,996,715
G
Rad18
RAD18 E3 ubiquitin protein ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RAD18 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
G
Rad54l
RAD54 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD54L mRNA
CTD
PMID:21641980
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Rasa2
RAS p21 protein activator 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RASA2 mRNA
CTD
PMID:26378955
NCBI chr 8:97,119,983...97,236,687
Ensembl chr 8:97,118,802...97,236,671
G
Rasgrp3
RAS guanyl releasing protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASGRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASGRP3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578
G
Rassf1
Ras association domain family member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASSF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rassf2
Ras association domain family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF2 mRNA
CTD
PMID:21641980
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
G
Rassf4
Ras association domain family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF4 mRNA
CTD
PMID:21641980
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
G
Rassf8
Ras association domain family member 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF8 mRNA
CTD
PMID:21641980
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP4 mRNA
CTD
PMID:21641980
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rbbp6
RB binding protein 6, ubiquitin ligase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RBBP6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RBBP6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:177,503,988...177,537,397
Ensembl chr 1:177,503,313...177,535,678
G
Rbbp8
RB binding protein 8, endonuclease
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP8 mRNA
CTD
PMID:21641980
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbfox1
RNA binding fox-1 homolog 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBFOX1 mRNA
CTD
PMID:21641980
NCBI chr10:8,152,198...10,248,120
Ensembl chr10:8,152,198...9,686,659
G
Rbl1
RB transcriptional corepressor like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA
CTD
PMID:21641980
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm25
RNA binding motif protein 25
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM25 mRNA
CTD
PMID:21641980
NCBI chr 6:103,271,775...103,319,090
Ensembl chr 6:103,271,801...103,317,854
G
Rbm26
RNA binding motif protein 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM26 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM26 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
G
Rbm3
RNA binding motif protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM3 mRNA
CTD
PMID:21641980
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Rbm39
RNA binding motif protein 39
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM39 mRNA
CTD
PMID:21641980
NCBI chr 3:144,662,998...144,696,222
Ensembl chr 3:144,663,001...144,696,213
G
Rbm5
RNA binding motif protein 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:108,420,220...108,449,481
Ensembl chr 8:108,420,222...108,449,430
G
Rc3h2
ring finger and CCCH-type domains 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RC3H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RC3H2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RC3H2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:21,121,531...21,186,711
Ensembl chr 3:21,110,679...21,179,933
G
Rcan1
regulator of calcineurin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RCAN1 mRNA
CTD
PMID:21641980
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rcn2
reticulocalbin 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RCN2 mRNA
CTD
PMID:26378955
NCBI chr 8:56,449,206...56,466,253
Ensembl chr 8:56,449,206...56,466,251
G
Reep3
receptor accessory protein 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of REEP3 mRNA
CTD
PMID:21641980
NCBI chr20:21,493,868...21,578,698
Ensembl chr20:21,493,954...21,578,697
G
Relb
RELB proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RELB mRNA
CTD
PMID:21641980
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rest
RE1-silencing transcription factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REST mRNA
CTD
PMID:26378955
NCBI chr14:30,859,109...30,879,828
Ensembl chr14:30,862,553...30,894,354
G
Rev3l
REV3 like, DNA directed polymerase zeta catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of REV3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REV3L mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
G
Rftn2
raftlin family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RFTN2 mRNA
CTD
PMID:21641980
NCBI chr 9:56,651,617...56,707,830
Ensembl chr 9:56,630,460...56,707,810
G
Rfx7
regulatory factor X, 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RFX7 mRNA
CTD
PMID:21641980
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
G
Rgs16
regulator of G-protein signaling 16
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RGS16 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs18
regulator of G-protein signaling 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS18 mRNA
CTD
PMID:21641980
NCBI chr13:56,493,134...56,516,045
Ensembl chr13:56,494,010...56,516,098
G
Rheb
Ras homolog, mTORC1 binding
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RHEB mRNA
CTD
PMID:26378955
NCBI chr 4:10,278,970...10,320,160
Ensembl chr 4:10,279,370...10,320,160
G
Rhoc
ras homolog family member C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOC mRNA
CTD
PMID:21641980
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rhof
ras homolog family member F, filopodia associated
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOF mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOF mRNA
CTD
PMID:21641980
NCBI chr12:33,422,375...33,446,689
Ensembl chr12:33,431,280...33,446,703
G
Rhoq
ras homolog family member Q
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOQ mRNA
CTD
PMID:21641980
NCBI chr 6:7,613,632...7,652,047
G
Rhov
ras homolog family member V
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RHOV mRNA
CTD
PMID:26378955
NCBI chr 3:106,260,774...106,270,009
Ensembl chr 3:106,260,776...106,269,479
G
Rif1
replication timing regulatory factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIF1 mRNA
CTD
PMID:21641980
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
G
Rig1
RNA sensor RIG-1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIGI mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Rilpl2
Rab interacting lysosomal protein-like 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RILPL2 mRNA
CTD
PMID:21641980
NCBI chr12:32,125,908...32,137,426
Ensembl chr12:32,125,886...32,137,418
G
Rimklb
ribosomal modification protein rimK-like family member B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RIMKLB mRNA
CTD
PMID:26378955
NCBI chr 4:155,664,392...155,706,888
Ensembl chr 4:155,664,375...155,706,711
G
Rims2
regulating synaptic membrane exocytosis 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIMS2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491
G
Rin1
Ras and Rab interactor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIN1 mRNA
CTD
PMID:21641980
NCBI chr 1:202,355,729...202,362,731
Ensembl chr 1:202,355,890...202,362,729
G
Rmnd1
required for meiotic nuclear division 1 homolog
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND1 mRNA
CTD
PMID:21641980
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
G
Rmnd5a
required for meiotic nuclear division 5 homolog A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND5A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RMND5A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:103,375,846...103,432,890
Ensembl chr 4:103,379,908...103,433,051
G
Rnase1
ribonuclease A family member 1, pancreatic
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNASE1 mRNA
CTD
PMID:26378955
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
G
Rnase4
ribonuclease A family member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNASE4 mRNA
CTD
PMID:21641980
NCBI chr15:24,312,765...24,330,112
Ensembl chr15:24,312,464...24,330,117
G
Rnf122
ring finger protein 122
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF122 mRNA
CTD
PMID:26378955
NCBI chr16:61,009,879...61,027,429
Ensembl chr16:61,009,879...61,027,448
G
Rnf144b
ring finger protein 144B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNF144B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RNF144B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
G
Rnf183
ring finger protein 183
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF183 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF183 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:75,877,111...75,886,253
Ensembl chr 5:75,876,003...75,886,191
G
Rnf19b
ring finger protein 19B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF19B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF19B mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rnf213
ring finger protein 213
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF213 mRNA
CTD
PMID:26378955
NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918
G
Rnf24
ring finger protein 24
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF24 mRNA
CTD
PMID:26378955
NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:118,525,349...118,541,080
G
Rnf38
ring finger protein 38
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF38 mRNA
CTD
PMID:26378955
NCBI chr 5:58,358,771...58,467,424
Ensembl chr 5:58,361,976...58,467,446
G
Rnf39
ring finger protein 39
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF39 mRNA
CTD
PMID:26378955
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
G
Rnf44
ring finger protein 44
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF44 mRNA
CTD
PMID:26378955
NCBI chr17:9,919,982...9,934,376
Ensembl chr17:9,919,993...9,932,193
G
Rnf6
ring finger protein 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF6 mRNA
CTD
PMID:26378955
NCBI chr12:8,816,797...8,826,870
Ensembl chr12:8,816,833...8,826,847
G
Ro60
Ro60, Y RNA binding protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RO60 mRNA
CTD
PMID:26378955
NCBI chr13:55,499,514...55,520,504
Ensembl chr13:55,499,534...55,520,504
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ROCK1 mRNA
CTD
PMID:26378955
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
G
Rp2
RP2 activator of ARL3 GTPase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RP2 mRNA
CTD
PMID:21641980
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
G
Rpl30
ribosomal protein L30
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL30 mRNA
CTD
PMID:21641980
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpl37
ribosomal protein L37
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RPL37 mRNA
CTD
PMID:26378955
NCBI chr 2:54,215,469...54,217,429
Ensembl chr 2:54,215,469...54,217,442
G
Rpl37a
ribosomal protein L37A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPL37A mRNA
CTD
PMID:26378955
NCBI chr 9:74,298,843...74,300,926
G
Rpl5
ribosomal protein L5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL5 mRNA
CTD
PMID:21641980
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rps17
ribosomal protein S17
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS17 mRNA
CTD
PMID:21641980
NCBI chr 1:135,295,920...135,298,506
Ensembl chr 1:135,295,919...135,298,535 Ensembl chr 8:135,295,919...135,298,535
G
Rps24
ribosomal protein S24
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS24 mRNA
CTD
PMID:21641980
NCBI chr16:89,538...94,267
Ensembl chr16:89,604...94,279
G
Rps27l
ribosomal protein S27-like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPS27L mRNA
CTD
PMID:26378955
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rps6ka2
ribosomal protein S6 kinase A2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RPS6KA2 mRNA
CTD
PMID:21641980
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6ka5
ribosomal protein S6 kinase A5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA
CTD
PMID:21641980
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KB1 mRNA
CTD
PMID:21641980
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA
CTD
PMID:26378955
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
Rsad2
radical S-adenosyl methionine domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RSAD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RSAD2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
Rsf1
remodeling and spacing factor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSF1 mRNA
CTD
PMID:26378955
NCBI chr 1:151,892,055...152,015,089
Ensembl chr 1:151,892,434...152,009,051
G
Rspo3
R-spondin 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSPO3 mRNA
CTD
PMID:26378955
NCBI chr 1:28,283,914...28,368,661
Ensembl chr 1:28,283,914...28,367,061
G
Rsrc2
arginine and serine rich coiled-coil 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RSRC2 mRNA
CTD
PMID:21641980
NCBI chr12:32,839,840...32,859,820
Ensembl chr12:32,839,809...32,859,799
G
RT1-A2
RT1 class Ia, locus A2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-T23 mRNA
CTD
PMID:21641980
NCBI chr20:4,870,939...4,910,183
G
RT1-Db1
RT1 class II, locus Db1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-EB1 mRNA
CTD
PMID:21641980
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Rtel1
regulator of telomere elongation helicase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTEL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTEL1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
G
Rtn1
reticulon 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTN1 mRNA
CTD
PMID:26378955
NCBI chr 6:90,763,212...90,983,436
Ensembl chr 6:90,763,216...90,983,436
G
Rtn4
reticulon 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RTN4 mRNA
CTD
PMID:21641980
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Rtp4
receptor (chemosensory) transporter protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTP4 mRNA
CTD
PMID:21641980
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
G
Rufy3
RUN and FYVE domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUFY3 mRNA
CTD
PMID:21641980
NCBI chr14:19,431,530...19,506,476
Ensembl chr14:19,432,524...19,507,004
G
Runx2
RUNX family transcription factor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUNX2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RUNX2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
S100a10
S100 calcium binding protein A10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of S100A10 mRNA
CTD
PMID:21641980
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a8
S100 calcium binding protein A8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A8 mRNA
CTD
PMID:26378955
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A9 mRNA
CTD
PMID:26378955
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sacm1l
SAC1 like phosphatidylinositide phosphatase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACM1L mRNA
CTD
PMID:21641980
NCBI chr 8:123,176,017...123,232,413
Ensembl chr 8:123,172,536...123,232,413
G
Sacs
sacsin molecular chaperone
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACS mRNA
CTD
PMID:21641980
NCBI chr15:35,285,783...35,370,335
Ensembl chr15:35,285,782...35,370,335
G
Samd9l
sterile alpha motif domain containing 9 like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAMD9L mRNA
CTD
PMID:21641980
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:31,361,669...31,376,415
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SAMHD1 mRNA
CTD
PMID:26378955
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Sap18
Sin3A associated protein 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SAP18 mRNA
CTD
PMID:21641980
NCBI chr15:31,943,228...31,947,534
Ensembl chr15:31,943,230...31,950,038 Ensembl chr10:31,943,230...31,950,038
G
Sap30l
SAP30-like
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SAP30L mRNA
CTD
PMID:26378955
NCBI chr10:41,979,730...41,992,307
Ensembl chr10:41,979,687...41,987,658
G
Sapcd1
suppressor APC domain containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAPCD1 mRNA
CTD
PMID:21641980
NCBI chr20:3,793,980...3,795,767
Ensembl chr20:3,793,967...3,795,790
G
Sash3
SAM and SH3 domain containing 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SASH3 mRNA
CTD
PMID:21641980
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
G
Sc5d
sterol-C5-desaturase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SC5D mRNA
CTD
PMID:21641980
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scaper
S-phase cyclin A-associated protein in the ER
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SCAPER mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SCAPER mRNA
CTD
PMID:26378955
NCBI chr 8:55,932,717...56,332,222
Ensembl chr 8:55,933,306...56,332,122
G
Scd2
stearoyl-Coenzyme A desaturase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCD2 mRNA
CTD
PMID:21641980
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
G
Scin
scinderin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SCIN mRNA
CTD
PMID:21641980
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
G
Scyl3
SCY1 like pseudokinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCYL3 mRNA
CTD
PMID:21641980
NCBI chr13:76,278,428...76,303,038
Ensembl chr13:76,278,428...76,301,716
G
Sdc3
syndecan 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC3 mRNA
CTD
PMID:21641980
NCBI chr 5:142,965,659...142,998,390
Ensembl chr 5:142,965,591...142,996,480
G
Sdc4
syndecan 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC4 mRNA
CTD
PMID:21641980
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
G
Selenbp1
selenium binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENBP1 mRNA
CTD
PMID:21641980
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Selenow
selenoprotein W
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENOW mRNA
CTD
PMID:21641980
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sema3e
semaphorin 3E
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA
CTD
PMID:21641980
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
G
Sema4a
semaphorin 4A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA4A mRNA
CTD
PMID:21641980
NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442
G
Sema4c
semaphorin 4C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4C mRNA
CTD
PMID:21641980
NCBI chr 9:38,791,668...38,802,171
Ensembl chr 9:38,791,670...38,802,128
G
Sema4g
semaphorin 4G
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4G mRNA
CTD
PMID:21641980
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
G
Sema5a
semaphorin 5A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA5A mRNA
CTD
PMID:21641980
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
G
Sema7a
semaphorin 7A (John Milton Hagen blood group)
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA7A mRNA
CTD
PMID:21641980
NCBI chr 8:58,348,448...58,370,536
Ensembl chr 8:58,348,448...58,370,536
G
Senp7
SUMO specific peptidase 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SENP7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SENP7 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:44,423,733...44,584,129
Ensembl chr11:44,423,735...44,564,711
G
Serbp1
Serpine1 mRNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERBP1 mRNA
CTD
PMID:21641980
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
G
Serinc2
serine incorporator 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERINC2 mRNA
CTD
PMID:21641980
NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364
G
Serinc3
serine incorporator 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERINC3 mRNA
CTD
PMID:21641980
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
G
Serpina1
serpin family A member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINA1 mRNA
CTD
PMID:26378955
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpina7
serpin family A member 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINA7 mRNA
CTD
PMID:26378955
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
G
Serpinb12
serpin family B member 12
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB12 mRNA
CTD
PMID:26378955
NCBI chr13:23,052,384...23,083,691
Ensembl chr13:23,052,448...23,083,691
G
Serpinb5
serpin family B member 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB5 mRNA
CTD
PMID:26378955
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpinb8
serpin family B member 8
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERPINB8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB8 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpinb9
serpin family B member 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpind1
serpin family D member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPIND1 mRNA
CTD
PMID:26378955
NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINE1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINE1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpini1
serpin family I member 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINI1 mRNA
CTD
PMID:26378955
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sesn1
sestrin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SESN1 mRNA
CTD
PMID:21641980
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Setd4
SET domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SETD4 mRNA
CTD
PMID:21641980
NCBI chr11:32,829,509...32,859,162
Ensembl chr11:32,838,063...32,858,243
G
Sfi1
SFI1 centrin binding protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFI1 mRNA
CTD
PMID:21641980
NCBI chr14:77,990,965...78,048,352
Ensembl chr14:77,990,965...78,048,255
G
Sfpq
splicing factor proline and glutamine rich
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFPQ mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SFPQ mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA
CTD
PMID:21641980
NCBI chr 2:233,750,838...233,784,817
Ensembl chr 2:233,750,838...233,784,784
G
Sik3
SIK family kinase 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SIK3 mRNA
CTD
PMID:21641980
NCBI chr 8:46,312,253...46,522,444
Ensembl chr 8:46,311,989...46,522,444
G
Skil
SKI-like proto-oncogene
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SKIL mRNA
CTD
PMID:21641980
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Slc11a1
solute carrier family 11 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc11a2
solute carrier family 11 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A2 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc12a3
solute carrier family 12 member 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC12A3 mRNA
CTD
PMID:26378955
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc15a3
solute carrier family 15 member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC15A3 mRNA
CTD
PMID:21641980
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc16a12
solute carrier family 16, member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A12 mRNA
CTD
PMID:23086747
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
G
Slc16a4
solute carrier family 16, member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A4 mRNA
CTD
PMID:21641980
NCBI chr 2:194,911,075...194,933,162
Ensembl chr 2:194,911,236...194,933,117
G
Slc1a4
solute carrier family 1 member 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC1A4 mRNA
CTD
PMID:26378955
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc20a2
solute carrier family 20 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC20A2 mRNA
CTD
PMID:21641980
NCBI chr16:69,460,850...69,551,418
Ensembl chr16:69,460,462...69,521,711
G
Slc22a4
solute carrier family 22 member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC22A4 mRNA
CTD
PMID:21641980
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc25a23
solute carrier family 25 member 23
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A23 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC25A23 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
G
Slc25a26
solute carrier family 25 member 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A26 mRNA
CTD
PMID:23086747
NCBI chr 4:127,036,704...127,131,026
Ensembl chr 4:127,036,742...127,131,020
G
Slc28a2
solute carrier family 28 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC28A2 mRNA
CTD
PMID:21641980
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc31a2
solute carrier family 31 member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC31A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC31A2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:75,738,008...75,748,542
Ensembl chr 5:75,738,024...75,748,542
G
Slc38a2
solute carrier family 38, member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC38A2 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc40a1
solute carrier family 40 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC40A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC40A1 mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Slc44a1
solute carrier family 44 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC44A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909
G
Slc48a1
solute carrier family 48 member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC48A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024
G
Slc4a7
solute carrier family 4 member 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC4A7 mRNA
CTD
PMID:21641980
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Slc5a3
solute carrier family 5 member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC5A3 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
G
Slc6a12
solute carrier family 6 member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A12 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 4:154,585,386...154,603,750
Ensembl chr 4:154,585,500...154,603,750
G
Slc6a13
solute carrier family 6 member 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A13 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC7A11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC7A11 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc8a1
solute carrier family 8 member A1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC8A1 mRNA
CTD
PMID:26378955
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9b2
solute carrier family 9 member B2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC9B2 mRNA
CTD
PMID:21641980
NCBI chr 2:223,726,982...223,761,234
Ensembl chr 2:223,736,354...223,761,225
G
Slco4a1
solute carrier organic anion transporter family, member 4a1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLCO4A1 mRNA
CTD
PMID:21641980 PMID:23086747
NCBI chr 3:167,559,177...167,578,307
Ensembl chr 3:167,559,316...167,578,305
G
Slf1
SMC5-SMC6 complex localization factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLF1 mRNA
CTD
PMID:21641980
NCBI chr 2:6,767,015...6,874,428
Ensembl chr 2:6,767,015...6,867,149
G
Slfn2
schlafen family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLFN2 mRNA
CTD
PMID:21641980
NCBI chr10:67,953,322...67,959,659
Ensembl chr10:67,953,171...67,959,458
G
Slfn9
schlafen family member 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLFN9 mRNA
CTD
PMID:21641980
NCBI chr10:67,909,105...67,955,912
Ensembl chr10:67,909,106...67,925,383
G
Slpi
secretory leukocyte peptidase inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLPI mRNA
CTD
PMID:21641980
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sltm
SAFB-like, transcription modulator
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLTM mRNA
CTD
PMID:21641980
NCBI chr 8:71,215,995...71,261,821
Ensembl chr 8:71,216,612...71,261,825
G
Smad6
SMAD family member 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMAD6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
G
Smad7
SMAD family member 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD7 mRNA
CTD
PMID:26378955
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smad9
SMAD family member 9
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD9 mRNA
CTD
PMID:26378955
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
G
Smc2
structural maintenance of chromosomes 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC2 mRNA
CTD
PMID:21641980
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Smc6
structural maintenance of chromosomes 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC6 mRNA
CTD
PMID:21641980
NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
G
Smg1
SMG1, nonsense mediated mRNA decay associated PI3K related kinase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMG1 mRNA
CTD
PMID:26378955
NCBI chr 1:172,441,892...172,543,667
Ensembl chr 1:172,444,936...172,543,698
G
Smoc1
SPARC related modular calcium binding 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMOC1 mRNA
CTD
PMID:26378955
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Smpd4
sphingomyelin phosphodiesterase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMPD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMPD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:83,362,534...83,386,257
Ensembl chr11:83,362,534...83,386,250
G
Smyd4
SET and MYND domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SMYD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SMYD4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:60,200,067...60,246,387
Ensembl chr10:60,200,114...60,246,387
G
Snai2
snail family transcriptional repressor 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAI2 mRNA
CTD
PMID:26378955
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snap23
synaptosome associated protein 23
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAP23 mRNA
CTD
PMID:26378955
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
G
Snord123
small nucleolar RNA, C/D box 123
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SNORD123 mRNA
CTD
PMID:21641980
NCBI chr 2:83,306,918...83,306,987
Ensembl chr 2:83,306,918...83,306,987
G
Snta1
syntrophin, alpha 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNTA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SNTA1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:142,876,285...142,906,737
Ensembl chr 3:142,876,296...142,906,709
G
Snx24
sorting nexin 24
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNX24 mRNA
CTD
PMID:21641980
NCBI chr18:46,670,987...46,826,070
Ensembl chr18:46,671,443...46,826,068
G
Soat1
sterol O-acyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SOAT1 mRNA
CTD
PMID:21641980
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
G
Socs3
suppressor of cytokine signaling 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SOCS3 mRNA
CTD
PMID:21641980
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SOD2 mRNA
CTD
PMID:26378955
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorbs2
sorbin and SH3 domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SORBS2 mRNA
CTD
PMID:26378955
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
G
Sord
sorbitol dehydrogenase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORD mRNA
CTD
PMID:26378955
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sorl1
sortilin related receptor 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORL1 mRNA
CTD
PMID:26378955
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Spag9
sperm associated antigen 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPAG9 mRNA
CTD
PMID:21641980
NCBI chr10:78,943,439...79,077,797
Ensembl chr10:78,943,479...79,077,797
G
Spata13
spermatogenesis associated 13
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPATA13 mRNA
CTD
PMID:21641980
NCBI chr15:34,778,479...34,907,645
Ensembl chr15:34,778,473...34,905,114
G
Spdl1
spindle apparatus coiled-coil protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPDL1 mRNA
CTD
PMID:21641980
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPP1 mRNA
CTD
PMID:26378955
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spry2
sprouty RTK signaling antagonist 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPRY2 mRNA
CTD
PMID:26378955
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Sqor
sulfide quinone oxidoreductase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQOR mRNA
CTD
PMID:21641980
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQSTM1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SQSTM1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRC mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SRC mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srek1
splicing regulatory glutamic acid and lysine rich protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SREK1 mRNA
CTD
PMID:21641980
NCBI chr 2:34,849,548...34,885,120
Ensembl chr 2:34,852,458...34,884,972
G
Srpk2
SRSF protein kinase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRPK2 mRNA
CTD
PMID:21641980
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srsf10
serine and arginine rich splicing factor 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF10 mRNA
CTD
PMID:21641980
NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768
G
Srsf3
serine and arginine rich splicing factor 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFRS3 mRNA
CTD
PMID:21641980
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srsf7
serine and arginine rich splicing factor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF7 mRNA
CTD
PMID:21641980
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Srxn1
sulfiredoxin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRXN1 mRNA
CTD
PMID:21641980
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ssb
small RNA binding exonuclease protection factor La
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSB mRNA
CTD
PMID:21641980
NCBI chr 3:54,616,616...54,626,203
Ensembl chr 3:54,616,619...54,626,203
G
Ssr1
signal sequence receptor subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSR1 mRNA
CTD
PMID:21641980
NCBI chr17:26,833,720...26,861,821
Ensembl chr17:26,833,741...26,861,821
G
St18
ST18 C2H2C-type zinc finger transcription factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST18 mRNA
CTD
PMID:26378955
NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST3GAL1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL6 mRNA
CTD
PMID:21641980
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST6GAL1 mRNA
CTD
PMID:21641980
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
St8sia4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST8SIA4 mRNA
CTD
PMID:21641980
NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653
G
Stac2
SH3 and cysteine rich domain 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAC2 mRNA
CTD
PMID:26378955
NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
G
Stard4
StAR-related lipid transfer domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD4 mRNA
CTD
PMID:21641980
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stard9
StAR-related lipid transfer domain containing 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD9 mRNA
CTD
PMID:21641980
NCBI chr 3:107,581,097...107,672,746
Ensembl chr 3:107,581,164...107,673,898
G
Stat2
signal transducer and activator of transcription 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAT2 mRNA
CTD
PMID:26378955
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
G
Stc2
stanniocalcin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STC2 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STC2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Steap4
STEAP4 metalloreductase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STEAP4 mRNA
CTD
PMID:26378955
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stk26
serine/threonine kinase 26
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STK26 mRNA
CTD
PMID:26378955
NCBI chr X:130,325,064...130,375,674
Ensembl chr X:130,310,885...130,374,291
G
Strn3
striatin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STRN3 mRNA
CTD
PMID:21641980
NCBI chr 6:69,047,776...69,134,102
Ensembl chr 6:69,047,776...69,134,102
G
Stx11
syntaxin 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of STX11 mRNA
CTD
PMID:21641980
NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164
G
Stxbp4
syntaxin binding protein 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP4 mRNA
CTD
PMID:21641980
NCBI chr10:75,301,868...75,458,741
Ensembl chr10:75,305,463...75,458,663
G
Stxbp5
syntaxin binding protein 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP5 mRNA
CTD
PMID:21641980
NCBI chr 1:4,182,489...4,335,290
Ensembl chr 1:4,185,529...4,335,101
G
Sulf2
sulfatase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SULF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SULF2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Suv39h2
SUV39H2 histone lysine methyltransferase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUV39H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUV39H2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:74,756,290...74,775,332
Ensembl chr17:74,756,306...74,775,332
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUZ12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUZ12 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Syn1
synapsin I
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SYN1 mRNA
CTD
PMID:21641980
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA
CTD
PMID:21641980
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Sytl4
synaptotagmin-like 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SYTL4 mRNA
CTD
PMID:26378955
NCBI chr X:97,135,496...97,185,867
Ensembl chr X:97,135,500...97,185,854
G
Taf15
TATA-box binding protein associated factor 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF15 mRNA
CTD
PMID:21641980
NCBI chr10:68,272,921...68,304,951
Ensembl chr10:68,272,969...68,304,949
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF1D mRNA
CTD
PMID:21641980
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Tafa3
TAFA chemokine like family member 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TAFA3 mRNA
CTD
PMID:26378955
NCBI chr 2:192,264,153...192,280,356
Ensembl chr 2:192,267,093...192,274,019
G
Tank
TRAF family member-associated NFKB activator
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TANK mRNA
CTD
PMID:26378955
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
G
Tap1
transporter 1, ATP binding cassette subfamily B member
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TAP1 mRNA
CTD
PMID:21641980
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tardbp
TAR DNA binding protein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TARDBP mRNA
CTD
PMID:21641980
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
G
Tatdn3
TatD DNase domain containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TATDN3 mRNA
CTD
PMID:26378955
NCBI chr13:102,634,254...102,649,069
Ensembl chr13:102,634,258...102,649,063
G
Tbc1d4
TBC1 domain family, member 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D4 mRNA
CTD
PMID:21641980
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tbc1d5
TBC1 domain family, member 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D5 mRNA
CTD
PMID:21641980
NCBI chr 9:3,503,328...4,017,131
Ensembl chr 9:3,513,623...4,016,913
G
Tbc1d8b
TBC1 domain family member 8B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D8B mRNA
CTD
PMID:21641980
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbxas1
thromboxane A synthase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TBXAS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TBXAS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Tcf12
transcription factor 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF12 mRNA
CTD
PMID:21641980
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
G
Tcf4
transcription factor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF4 mRNA
CTD
PMID:21641980
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tcn2
transcobalamin 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TCN2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
G
Tdo2
tryptophan 2,3-dioxygenase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TDO2 mRNA
CTD
PMID:26378955
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Tert
telomerase reverse transcriptase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TERT mRNA
CTD
PMID:26378955
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tet2
tet methylcytosine dioxygenase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TET2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of TET2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
G
Tf
transferrin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRF mRNA
CTD
PMID:21641980 PMID:23086747 PMID:26378955
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfdp2
transcription factor Dp-2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA
CTD
PMID:21641980
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
G
Tfec
transcription factor EC
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TFEC mRNA
CTD
PMID:21641980
NCBI chr 4:45,106,129...45,180,236
Ensembl chr 4:45,107,641...45,180,236
G
Tfrc
transferrin receptor
multiple interactions
ISO
[Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of TFRC mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFRC mRNA
CTD
PMID:21641980 PMID:23086747 PMID:25522732
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFB1 mRNA
CTD
PMID:26378955
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Tgm2
transglutaminase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGM2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tgm5
transglutaminase 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM5 mRNA
CTD
PMID:26378955
NCBI chr 3:108,008,087...108,044,013
Ensembl chr 3:108,008,143...108,043,976
G
Thap2
THAP domain containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THAP2 mRNA
CTD
PMID:26378955
NCBI chr 7:50,992,912...51,007,582
Ensembl chr 7:50,995,793...51,008,061
G
Thbs1
thrombospondin 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THBS1 mRNA
CTD
PMID:26378955
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thoc1
THO complex subunit 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC1 mRNA
CTD
PMID:21641980
NCBI chr18:983,824...1,019,123
Ensembl chr18:983,824...1,019,114
G
Thoc2
THO complex subunit 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC2 mRNA
CTD
PMID:21641980
NCBI chr X:120,634,966...120,749,569
Ensembl chr X:120,634,968...120,749,513
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIAL1 mRNA
CTD
PMID:21641980
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Tifa
TRAF-interacting protein with forkhead-associated domain
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFA mRNA
CTD
PMID:21641980
NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:216,234,774...216,267,841
G
Tifab
TIFA inhibitor
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFAB mRNA
CTD
PMID:21641980
NCBI chr17:8,433,406...8,436,541
Ensembl chr17:8,431,635...8,436,592
G
Timm9
translocase of inner mitochondrial membrane 9
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIMM9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMM9 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Timp3
TIMP metallopeptidase inhibitor 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMP3 mRNA
CTD
PMID:26378955
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIPARP mRNA
CTD
PMID:26378955
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tlcd2
TLC domain containing 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TLCD2 mRNA
CTD
PMID:21641980
NCBI chr10:60,310,577...60,314,263
Ensembl chr10:60,311,099...60,313,622
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR4 mRNA
CTD
PMID:21641980
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr7
toll-like receptor 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR7 mRNA
CTD
PMID:21641980
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
G
Tm9sf3
transmembrane 9 superfamily member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TM9SF3 mRNA
CTD
PMID:21641980
NCBI chr 1:240,032,060...240,085,125
Ensembl chr 1:240,035,003...240,084,776
G
Tmed10
transmembrane p24 trafficking protein 10
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMED10 mRNA
CTD
PMID:21641980
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmem140
transmembrane protein 140
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM140 mRNA
CTD
PMID:21641980
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
G
Tmem170b
transmembrane protein 170B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM170B mRNA
CTD
PMID:21641980
NCBI chr17:23,131,151...23,169,946
Ensembl chr17:23,131,456...23,170,248
G
Tmem171
transmembrane protein 171
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM171 mRNA
CTD
PMID:21641980
NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049
G
Tmem202
transmembrane protein 202
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM202 mRNA
CTD
PMID:21641980
NCBI chr 8:59,910,824...59,919,342
Ensembl chr 8:59,910,824...59,916,609
G
Tmem38b
transmembrane protein 38B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM38B mRNA
CTD
PMID:21641980
NCBI chr 5:68,460,304...68,496,026
Ensembl chr 5:68,460,304...68,496,025
G
Tmem41b
transmembrane protein 41B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM41B mRNA
CTD
PMID:21641980
NCBI chr 1:164,012,585...164,026,967
Ensembl chr 1:164,012,592...164,026,933
G
Tmem51
transmembrane protein 51
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM51 mRNA
CTD
PMID:21641980
NCBI chr 5:154,325,853...154,375,882
Ensembl chr 5:154,325,856...154,375,882
G
Tmem86a
transmembrane protein 86A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM86A mRNA
CTD
PMID:21641980
NCBI chr 1:97,595,910...97,600,260
Ensembl chr 1:97,595,842...97,600,260
G
Tmpo
thymopoietin
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMPO mRNA
CTD
PMID:21641980
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmprss4
transmembrane serine protease 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TMPRSS4 mRNA
CTD
PMID:26378955
NCBI chr 8:45,475,819...45,508,409
Ensembl chr 8:45,476,053...45,508,409
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNF mRNA Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF protein]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased secretion of TNF protein]
CTD
PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFAIP2 mRNA
CTD
PMID:21641980
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP3 mRNA
CTD
PMID:26378955
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip8
TNF alpha induced protein 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP8 mRNA
CTD
PMID:26378955
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf12a
TNF receptor superfamily member 12A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TNFRSF12A mRNA
CTD
PMID:26378955
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFRSF1B mRNA
CTD
PMID:21641980
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF10 mRNA
CTD
PMID:26378955
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf12
TNF superfamily member 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFSF12 mRNA
CTD
PMID:21641980
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
G
Tnfsf13b
TNF superfamily member 13b
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF13B mRNA
CTD
PMID:26378955
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnip1
TNFAIP3 interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNIP1 mRNA
CTD
PMID:21641980
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Tnks2
tankyrase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNKS2 mRNA
CTD
PMID:26378955
NCBI chr 1:234,567,888...234,621,079
Ensembl chr 1:234,567,858...234,621,079
G
Tnnc1
troponin C1, slow skeletal and cardiac type
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNNC1 mRNA
CTD
PMID:26378955
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
G
Tnrc6b
trinucleotide repeat containing adaptor 6B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TNRC6B mRNA
CTD
PMID:21641980
NCBI chr 7:112,252,351...112,469,829
Ensembl chr 7:112,252,359...112,461,790
G
Top2a
DNA topoisomerase II alpha
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TOP2A mRNA
CTD
PMID:26378955
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Topbp1
DNA topoisomerase II binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TOPBP1 mRNA
CTD
PMID:21641980
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tox2
TOX high mobility group box family member 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TOX2 mRNA
CTD
PMID:26378955
NCBI chr 3:151,853,294...151,980,086
Ensembl chr 3:151,853,294...151,980,749
G
Tp53
tumor protein p53
multiple interactions
EXP
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased phosphorylation of TP53 protein]
CTD
PMID:31163222 PMID:32402895
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRP53INP1 mRNA
CTD
PMID:21641980
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpbg
trophoblast glycoprotein
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TPBG mRNA
CTD
PMID:21641980
NCBI chr 8:86,793,953...86,797,324
Ensembl chr 8:86,793,749...86,797,741
G
Tpd52l1
TPD52 like 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TPD52L1 mRNA
CTD
PMID:26378955
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Traf1
TNF receptor-associated factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF1 mRNA
CTD
PMID:21641980
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf3ip1
TRAF3 interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRAF3IP1 mRNA
CTD
PMID:21641980
NCBI chr 9:92,073,622...92,110,427
Ensembl chr 9:92,073,640...92,108,977
G
Traf5
TNF receptor-associated factor 5
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRAF5 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr13:103,569,944...103,618,747
Ensembl chr13:103,572,314...103,618,709
G
Trex1
three prime repair exonuclease 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TREX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TREX1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
G
Trim16
tripartite motif-containing 16
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM16 mRNA
CTD
PMID:26378955
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
G
Trim2
tripartite motif-containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM2 mRNA
CTD
PMID:26378955
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim29
tripartite motif-containing 29
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM29 mRNA
CTD
PMID:26378955
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim37
tripartite motif-containing 37
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM37 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM37 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:71,943,384...72,075,563
Ensembl chr10:71,943,375...72,075,558
G
Trim44
tripartite motif-containing 44
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM44 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:88,593,619...88,729,085
Ensembl chr 3:88,592,719...88,729,188
G
Trim5
tripartite motif-containing 5
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM5 mRNA
CTD
PMID:26378955
NCBI chr 1:158,720,407...158,737,393
Ensembl chr 1:158,720,410...158,814,012
G
Trim59
tripartite motif-containing 59
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM59 mRNA
CTD
PMID:26378955
NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031
G
Trim6
tripartite motif containing 6
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM6 mRNA
CTD
PMID:26378955
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
G
Trip11
thyroid hormone receptor interactor 11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIP11 mRNA
CTD
PMID:21641980
NCBI chr 6:120,995,242...121,067,693
Ensembl chr 6:120,998,733...121,067,781
G
Trmt6
tRNA methyltransferase 6 non-catalytic subunit
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRMT6 mRNA
CTD
PMID:21641980
NCBI chr 3:120,074,899...120,086,639
Ensembl chr 3:120,074,911...120,086,559
G
Trpc2
transient receptor potential cation channel subfamily C member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPC2 mRNA
CTD
PMID:21641980
NCBI chr 1:156,460,009...156,473,039
Ensembl chr 1:156,440,305...156,473,073
G
Trpc5
transient receptor potential cation channel, subfamily C, member 5
increases activity
ISO
Succimer results in increased activity of TRPC5 protein
CTD
PMID:21984481
NCBI chr X:107,946,163...108,230,991
Ensembl chr X:107,939,131...108,230,991
G
Trpm7
transient receptor potential cation channel, subfamily M, member 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPM7 mRNA
CTD
PMID:26378955
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
G
Trps1
transcriptional repressor GATA binding 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPS1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905
G
Tsc22d1
TSC22 domain family, member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSC22D1 mRNA
CTD
PMID:21641980
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tsc22d3
TSC22 domain family, member 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:21641980
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tshz3
teashirt zinc finger homeobox 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TSHZ3 mRNA
CTD
PMID:26378955
NCBI chr 1:89,386,732...89,460,719
Ensembl chr 1:89,381,858...89,460,874
G
Tspan14
tetraspanin 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSPAN14 mRNA
CTD
PMID:21641980
NCBI chr16:16,784,242...16,841,368
Ensembl chr16:16,783,234...16,841,400
G
Tspoap1
TSPO associated protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSPOAP1 mRNA
CTD
PMID:21641980
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
G
Ttc14
tetratricopeptide repeat domain 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC14 mRNA
CTD
PMID:21641980
NCBI chr 2:116,653,543...116,665,072
Ensembl chr 2:116,653,595...116,664,158
G
Ttc3
tetratricopeptide repeat domain 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TTC3 mRNA
CTD
PMID:26378955
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Ttc7a
tetratricopeptide repeat domain 7A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC7 mRNA
CTD
PMID:21641980
NCBI chr 6:7,159,285...7,261,826
Ensembl chr 6:7,159,061...7,261,892
G
Ttll11
tubulin tyrosine ligase like11
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTLL11 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TTLL11 mRNA
CTD
PMID:21641980
NCBI chr 3:19,109,891...19,335,077
Ensembl chr 3:19,110,284...19,335,969
G
Tug1
taurine up-regulated 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TUG1 mRNA
CTD
PMID:21641980
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
G
Txn1
thioredoxin 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXN1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TXN mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txndc15
thioredoxin domain containing 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXNDC15 mRNA
CTD
PMID:21641980
NCBI chr17:8,898,074...8,910,538
Ensembl chr17:8,845,084...8,910,539
G
Uba3
ubiquitin-like modifier activating enzyme 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBA3 mRNA
CTD
PMID:21641980
NCBI chr 4:129,789,526...129,810,707
Ensembl chr 4:129,789,204...129,810,606
G
Uba7
ubiquitin-like modifier activating enzyme 7
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBA7 mRNA
CTD
PMID:21641980
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ubap2l
ubiquitin associated protein 2-like
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBAP2L mRNA
CTD
PMID:21641980
NCBI chr 2:175,438,703...175,494,085
Ensembl chr 2:175,438,703...175,493,998
G
Ube2i
ubiquitin-conjugating enzyme E2I
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBE2I mRNA
CTD
PMID:26378955
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBE2L6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UBE2L6 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ubr3
ubiquitin protein ligase E3 component n-recognin 3
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBR3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBR3 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:54,649,803...54,806,779
Ensembl chr 3:54,649,992...54,806,247
G
Ubxn2b
UBX domain protein 2B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBXN2B mRNA
CTD
PMID:21641980
NCBI chr 5:19,303,634...19,333,181
Ensembl chr 5:19,303,682...19,326,849
G
Ucp2
uncoupling protein 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UCP2 mRNA
CTD
PMID:21641980
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Unc13a
unc-13 homolog A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UNC13A mRNA
CTD
PMID:26378955
NCBI chr16:18,333,910...18,381,813
Ensembl chr16:18,336,229...18,381,872
G
Ung
uracil-DNA glycosylase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UNG mRNA
CTD
PMID:21641980
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Upf2
UPF2, regulator of nonsense mediated mRNA decay
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UPF2 mRNA
CTD
PMID:21641980
NCBI chr17:72,224,575...72,335,896
Ensembl chr17:72,225,316...72,335,855
G
Upp1
uridine phosphorylase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA
CTD
PMID:21641980
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Usp1
ubiquitin specific peptidase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP1 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
G
Usp16
ubiquitin specific peptidase 16
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP16 mRNA
CTD
PMID:26378955
NCBI chr11:26,681,359...26,711,313
Ensembl chr11:26,681,414...26,710,539
G
Usp18
ubiquitin specific peptidase 18
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of USP18 mRNA
CTD
PMID:21641980
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp2
ubiquitin specific peptidase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Usp34
ubiquitin specific peptidase 34
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP34 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP34 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp37
ubiquitin specific peptidase 37
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP37 mRNA
CTD
PMID:26378955
NCBI chr 9:76,018,863...76,118,732
Ensembl chr 9:76,018,991...76,084,044
G
Usp47
ubiquitin specific peptidase 47
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP47 mRNA
CTD
PMID:26378955
NCBI chr 1:166,152,104...166,235,312
Ensembl chr 1:166,152,199...166,235,312
G
Usp9x
ubiquitin specific peptidase 9, X-linked
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP9X mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of USP9X mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
G
Utrn
utrophin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTRN mRNA
CTD
PMID:26378955
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
G
Uty
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTY mRNA
CTD
PMID:26378955
NCBI chr Y:942,838...1,105,313
Ensembl chr Y:924,168...1,103,422
G
Vav3
vav guanine nucleotide exchange factor 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VAV3 mRNA
CTD
PMID:26378955
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
G
Vcf2
VCP nuclear cofactor family member 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCF2 mRNA
CTD
PMID:21641980
NCBI chr X:19,310,182...19,393,156
Ensembl chr X:19,349,560...19,378,486
G
Vcpip1
valosin containing protein interacting protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCPIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VCPIP1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:9,534,247...9,560,889
Ensembl chr 5:9,534,129...9,562,040
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VEGFA mRNA
CTD
PMID:26378955
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of VEGFC mRNA
CTD
PMID:21641980
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vldlr
very low density lipoprotein receptor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VLDLR mRNA
CTD
PMID:26378955
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vps18
VPS18 core subunit of CORVET and HOPS complexes
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS18 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:106,279,444...106,290,298
Ensembl chr 3:106,279,425...106,291,964
G
Vps41
VPS41 subunit of HOPS complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS41 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS41 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:46,063,132...46,227,533
Ensembl chr17:46,063,124...46,227,791
G
Vps50
VPS50 subunit of EARP/GARPII complex
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS50 mRNA
CTD
PMID:21641980
NCBI chr 4:31,484,424...31,585,617
Ensembl chr 4:31,484,463...31,585,617
G
Vtn
vitronectin
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VTN mRNA
CTD
PMID:26378955
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
G
Vwf
von Willebrand factor
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VWF mRNA
CTD
PMID:26378955
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wbp4
WW domain binding protein 4
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of WBP4 mRNA
CTD
PMID:26378955
NCBI chr15:54,862,700...54,890,668
Ensembl chr15:54,862,843...54,890,647
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDHD1 mRNA
CTD
PMID:21641980
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Wdpcp
WD repeat containing planar cell polarity effector
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDPCP mRNA
CTD
PMID:21641980
NCBI chr14:95,645,955...95,977,120
Ensembl chr14:95,646,038...95,977,113
G
Wdr12
WD repeat domain 12
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR12 mRNA
CTD
PMID:21641980
NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469
G
Wdr26
WD repeat domain 26
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR26 mRNA
CTD
PMID:21641980
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
G
Wipf1
WAS/WASL interacting protein family, member 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WIPF1 mRNA
CTD
PMID:21641980
NCBI chr 3:58,314,521...58,416,668
Ensembl chr 3:58,314,542...58,372,742
G
Wwox
WW domain-containing oxidoreductase
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of WWOX mRNA
CTD
PMID:21641980
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwp1
WW domain containing E3 ubiquitin protein ligase 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WWP1 mRNA
CTD
PMID:21641980
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
G
Xaf1
XIAP associated factor 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of XAF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of XAF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xrn2
5'-3' exoribonuclease 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of XRN2 mRNA
CTD
PMID:26378955
NCBI chr 3:134,436,916...134,509,308
Ensembl chr 3:134,437,109...134,509,306
G
Xylt2
xylosyltransferase 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of XYLT2 mRNA
CTD
PMID:21641980
NCBI chr10:79,605,910...79,619,482
Ensembl chr10:79,606,007...79,619,391
G
Zbp1
Z-DNA binding protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBP1 mRNA
CTD
PMID:21641980
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
G
Zbtb20
zinc finger and BTB domain containing 20
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZBTB20 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
G
Zbtb32
zinc finger and BTB domain containing 32
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBTB32 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB32 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:85,841,931...85,851,116
Ensembl chr 1:85,841,931...85,844,236
G
Zbtb4
zinc finger and BTB domain containing 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
G
Zbtb43
zinc finger and BTB domain containing 43
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB43 mRNA
CTD
PMID:26378955
NCBI chr 3:16,744,535...16,763,854
Ensembl chr 3:16,744,535...16,763,909
G
Zbtb7a
zinc finger and BTB domain containing 7a
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB7A mRNA
CTD
PMID:26378955
NCBI chr 7:8,561,015...8,578,243
Ensembl chr 7:8,563,779...8,576,539
G
Zbtb8a
zinc finger and BTB domain containing 8a
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB8A mRNA
CTD
PMID:26378955
NCBI chr 5:141,693,189...141,721,464
Ensembl chr 5:141,693,189...141,721,344
G
Zc3h11a
zinc finger CCCH-type containing 11A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H11A mRNA
CTD
PMID:26378955
NCBI chr13:45,073,422...45,113,901
Ensembl chr13:45,071,718...45,114,009
G
Zc3h12a
zinc finger CCCH type containing 12A
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12A mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zc3h12c
zinc finger CCCH type containing 12C
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12C mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:52,448,320...52,504,315
G
Zc3h13
zinc finger CCCH type containing 13
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZC3H13 mRNA
CTD
PMID:26378955
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zc3h15
zinc finger CCCH-type containing 15
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H15 mRNA
CTD
PMID:26378955
NCBI chr 3:68,744,591...68,764,335
Ensembl chr 3:68,744,604...68,764,333
G
Zcchc2
zinc finger CCHC-type containing 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZCCHC2 mRNA
CTD
PMID:26378955
NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,119,568...22,166,373
G
Zcchc7
zinc finger CCHC-type containing 7
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZCCHC7 mRNA
CTD
PMID:26378955
NCBI chr 5:58,992,558...59,173,308
Ensembl chr 5:58,993,290...59,173,300
G
Zdhhc14
zinc finger DHHC-type palmitoyltransferase 14
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZDHHC14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZDHHC14 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:46,069,127...46,340,806
Ensembl chr 1:46,069,127...46,330,488
G
Zdhhc2
zinc finger DHHC-type palmitoyltransferase 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZDHHC2 mRNA
CTD
PMID:26378955
NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060
G
Zdhhc21
zinc finger DHHC-type palmitoyltransferase 21
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZDHHC21 mRNA
CTD
PMID:26378955
NCBI chr 5:97,227,621...97,286,866
Ensembl chr 5:97,229,345...97,286,537
G
Zeb2
zinc finger E-box binding homeobox 2
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZEB2 mRNA
CTD
PMID:26378955
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
G
Zfc3h1
zinc finger, C3H1-type containing
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFC3H1 mRNA
CTD
PMID:26378955
NCBI chr 7:51,008,251...51,064,666
Ensembl chr 7:51,007,984...51,064,661
G
Zfhx4
zinc finger homeobox 4
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFHX4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFHX4 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:96,224,763...96,408,245
Ensembl chr 2:96,224,767...96,408,228
G
Zfp146
zinc finger protein 146
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF146 mRNA
CTD
PMID:26378955
NCBI chr 1:85,409,570...85,421,835
Ensembl chr 1:85,409,373...85,436,275
G
Zfp148
zinc finger protein 148
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP148 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP148 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
G
Zfp185
zinc finger protein 185
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP185 mRNA
CTD
PMID:26378955
NCBI chr X:150,831,869...150,877,652
Ensembl chr X:150,831,862...150,874,810
G
Zfp207
zinc finger protein 207
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP207 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP207 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386
G
Zfp266
zinc finger protein 266
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP266 mRNA
CTD
PMID:21641980
NCBI chr 8:19,030,766...19,061,381
Ensembl chr 8:19,030,768...19,060,937
G
Zfp267
zinc finger protein 267
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP267 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP267 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 2:119,017,280...119,035,885
Ensembl chr 2:119,017,285...119,031,900
G
Zfp280d
zinc finger protein 280D
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP280D mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF280D mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 8:72,992,655...73,080,482
Ensembl chr 8:72,992,650...73,080,480
G
Zfp292
zinc finger protein 292
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP292 mRNA
CTD
PMID:26378955
NCBI chr 5:49,384,177...49,468,177
Ensembl chr 5:49,387,893...49,468,265
G
Zfp296
zinc finger protein 296
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP296 mRNA
CTD
PMID:26378955
NCBI chr 1:79,228,649...79,231,866
Ensembl chr 1:79,228,401...79,231,866
G
Zfp329
zinc finger protein 329
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP329 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZFP329 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:73,403,067...73,498,349
Ensembl chr 1:73,402,972...73,422,037
G
Zfp36
zinc finger protein 36
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP36 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp367
zinc finger protein 367
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP367 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP367 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
G
Zfp36l1
zinc finger protein 36, C3H type-like 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36L1 mRNA
CTD
PMID:26378955
NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748
G
Zfp386
zinc finger protein 386 (Kruppel-like)
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF519 mRNA
CTD
PMID:26378955
NCBI chr 6:136,966,547...136,984,013
Ensembl chr 6:136,966,586...136,983,441
G
Zfp394
zinc finger protein 394
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZKSCAN14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZKSCAN14 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:9,409,047...9,417,228
Ensembl chr12:9,409,078...9,417,246
G
Zfp420
zinc finger protein 420
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF420 mRNA
CTD
PMID:26378955
NCBI chr 1:85,092,810...85,143,682
Ensembl chr 1:85,093,085...85,106,693 Ensembl chr 1:85,093,085...85,106,693
G
Zfp444
zinc finger protein 444
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP444 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP444 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:67,709,052...67,729,283
Ensembl chr 1:67,711,152...67,728,367
G
Zfp445
zinc finger protein 445
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP445 mRNA
CTD
PMID:26378955
NCBI chr 8:122,453,175...122,473,355
Ensembl chr 8:122,454,328...122,473,286
G
Zfp503
zinc finger protein 503
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP503 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP503 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848
G
Zfp518a
zinc finger protein 518A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF518A mRNA
CTD
PMID:26378955
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
G
Zfp605
zinc finger protein 605
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF605 mRNA
CTD
PMID:26378955
NCBI chr12:46,542,771...46,575,074
Ensembl chr12:46,545,073...46,575,828
G
Zfp638
zinc finger protein 638
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP638 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP638 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845
G
Zfp644
zinc finger protein 644
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP644 mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF644 mRNA
CTD
PMID:26378955
NCBI chr14:3,105,002...3,179,961
Ensembl chr14:3,105,178...3,179,940
G
Zfp799
zinc finger protein 799
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP799 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP799 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 7:11,894,224...11,910,809
Ensembl chr 7:11,898,149...11,910,798
G
Zfp800
zinc finger protein 800
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP800 mRNA
CTD
PMID:26378955
NCBI chr 4:56,798,326...56,849,766
Ensembl chr 4:56,826,997...56,849,791
G
Zfp804a
zinc finger protein 804A
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF804A mRNA
CTD
PMID:26378955
NCBI chr 3:67,033,481...67,267,769
Ensembl chr 3:67,034,170...67,263,607
G
Zfp831
zinc finger protein 831
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF831 mRNA
CTD
PMID:26378955
NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:163,438,006...163,509,095
G
Zfp91
zinc finger protein 91
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP91 mRNA
CTD
PMID:26378955
NCBI chr 1:209,891,344...209,928,890
Ensembl chr 1:209,891,344...209,927,762
G
Zfp955b
zinc finger protein 955B
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP955B mRNA
CTD
PMID:21641980
NCBI chr 7:12,610,224...12,625,537
Ensembl chr 7:12,610,196...12,622,587
G
Zfr
zinc finger RNA binding protein
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFR mRNA [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFR mRNA
CTD
PMID:26378955
NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:61,137,611...61,200,322
G
Zfyve16
zinc finger FYVE-type containing 16
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE16 mRNA
CTD
PMID:26378955
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
G
Zfyve21
zinc finger FYVE-type containing 21
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFYVE21 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE21 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 6:130,873,979...130,894,618
Ensembl chr 6:130,873,912...130,894,411
G
Zik1
zinc finger protein interacting with K protein 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZIK1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZIK1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:64,916,831...64,963,590
Ensembl chr 1:64,916,836...64,925,897
G
Zkscan1
zinc finger with KRAB and SCAN domains 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZKSCAN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr12:16,966,287...16,987,680
Ensembl chr12:16,966,654...16,983,865
G
Zmym3
zinc finger MYM-type containing 3
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYM3 mRNA
CTD
PMID:26378955
NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782
G
Zmynd15
zinc finger, MYND-type containing 15
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZMYND15 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZMYND15 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
G
Zmynd19
zinc finger, MYND-type containing 19
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZMYND19 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND19 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 3:7,758,133...7,769,722
Ensembl chr 3:7,758,133...7,767,514
G
Zmynd8
zinc finger, MYND-type containing 8
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND8 mRNA
CTD
PMID:26378955
NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463
G
Znrf1
zinc and ring finger 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZNRF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNRF1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr19:39,496,414...39,581,600
Ensembl chr19:39,496,527...39,580,969
G
Znrf2
zinc and ring finger 2
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZNRF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNRF2 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 4:83,950,406...84,032,676
Ensembl chr 4:83,949,309...84,027,818
G
Zranb1
zinc finger RANBP2-type containing 1
multiple interactions
ISO
[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZRANB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZRANB1 mRNA
CTD
PMID:21641980 PMID:26378955
NCBI chr 1:187,725,354...187,780,129
Ensembl chr 1:187,724,320...187,779,655
G
Zup1
zinc finger containing ubiquitin peptidase 1
multiple interactions
ISO
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZUP1 mRNA
CTD
PMID:26378955
NCBI chr20:30,785,226...30,815,377
Ensembl chr20:30,785,227...30,815,306
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all